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Uncoupling proteins (UCPs) are a family of highly conserved proteins that is 
located on the inner mitochondrial membrane (IMM) and  “uncouple” the 
electrochemical proton gradient formed by the electron transport chain (ETC) 
from ATP production. The first discovered uncoupling protein 1 (UCP1) is 
generally believed to mediate the proton leak-dependent thermogenesis in 
rodents and human neonates, but the physiological and biochemical functions of 
the homologs UCP2-5 are still under debate.  
Our research focuses on UCP3, the homolog prevalently expressed in skeletal 
muscle (SKM), and also detected in heart, BAT and other smooth-muscle 
containing organs at lower levels. Since skeletal muscle and heart are important 
metabolic organs, UCP3 has long been speculated to have a pivotal role in 
maintaining the mitochondrial metabolism. Several biochemical roles have been 
attributed to UCP3, including the regulation of fatty-acid transport and oxidation, 
reactive oxygen species (ROS) scavenging and calcium uptake. And several 
proteins have been identified to directly bind with UCP3 and facilitate its function. 
But to further understand how UCP3 relates to different aspects of mitochondrial 
functions, a more comprehensive profile of the UCP3 interaction partners is 
needed. The data I obtained from the mass spectrometry-based experiment 
successfully gave a list of over 170 potential proteins that may directly or 
indirectly interact with UCP3, and several novel functions of UCP3 are implied by 
these protein-protein interactions. 
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Additionally, researches have shown that the metabolic defects (including the 
accumulation of ROS and certain metabolites) are important contributing factors 
to the epigenetic changes. Considering the biochemical roles of UCP3 in 
sustaining the normal mitochondrial metabolism, we hypothesize that UCP3 has 
a novel function in regulating the genomic DNA methylation processes, and the 
loss of UCP3 will lead to aberrant DNA methylation changes. The data I obtained 
from the pilot study confirms this hypothesis and indicates the potential role of 
UCP3 in maintaining normal epigenetic marks. But further experiment is still 
needed to investigate the regulatory pathway between UCP3 and DNA 
methylation.  
The physiological role of UCP3 in defending against cancer, diabetes and obesity 
has been discussed, but the mechanisms how UCP3 protect the organism from 
these diseases have not been elucidated. Since the occurrences of these 
diseases are always characterized by aberrant epigenetic marks and altered 
metabolism, and understanding of UCP3 functions may be of significant 
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Chapter 1   Introduction 
 
1.1 Mitochondrial Metabolism 
The mitochondrial respiration pathways are conserved in almost all living 
organisms. Compared to glycolysis, it is much more efficient in generating 
adenosine triphosphate (ATP), the high-energy intermediates used in the 
majority of biological processes. In this sense, the mitochondria are responsible 
for fueling the cellular energy demands for most of the time. 
The biochemical reactions happened in the mitochondria are very complicated. 
The most well-known pathways are the tricarboxylic acid (TCA) cycle and the 
electron transport chain (ETC), but other reactions (including the fatty-acid 
oxidation, the folate cycle pathway, and apoptosis) are also crucial in the normal 
function and even survival of cells. This thesis will focus primarily on the TCA 
cycle and ETC, but will also involve some of the other reactions in later sections. 
 
1.1.1 The Mitochondrion 
Mitochondria are membranous organelles existing in almost all eukaryotic cells. 
According to the “Endosymbiotic Theory”, mitochondria originated from symbiosis 
between different prokaryotic cells. After millions of years of evolution, 
mitochondria have become highly-specialized and indispensible organelles that 
primarily focus on energy production. 
The mitochondrial space is separated by two phospholipid membranes, resulting 
in four distinct compartments: the outer mitochondrial membrane (OMM), 
intermembrane space, the inner mitochondrial membrane (IMM), and the matrix. 
The outer mitochondrial membrane encloses the entire organelle and is fully 
permeable to small molecules due to a large number of porin channels. The 
intermembrane space is the compartment between the outer and inner 
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membranes. Due to the permeability of the OMM, the intermembrane space has 
similar small molecule concentrations as the cytoplasm. The inner mitochondrial 
membrane contains a high density of proteins, including various transporters and 
the complexes in the electron transport chain (ETC), which is responsible for the 
majority of ATP production in the cell. Meanwhile, the IMM is highly impermeable 
due to the absence of porin channels, and this property maintains the proton 
gradient that is necessary for mitochondrial functions. The matrix is the 
compartment where TCA cycle and many other mitochondrial enzymatic 
reactions take place. It is able to provide the electron donors (NADH and FADH2) 
that are necessary for the electron transport chain to operate. Because of the 
importance of ATP production in cell metabolism, the number of mitochondria is 
always correlated with the cellular metabolic level. For example, the highly 
metabolic organs such as muscle and liver can contain hundreds of 
mitochondria. And research has shown that exercises can further induce the 
biogenesis of mitochondria in skeletal muscle to meet the increased energy 
demand (Hood, 2009). 
 
1.1.2 The Citric Acid Cycle 
Carbohydrate is the most common food substrate in human diet. After its 
consumption, the digestive system breaks it down to glucose before entering the 
cell. Then the glucose is transported into the cell by the GLUT transporters, and 
finally be used to produce large amount of ATP through the citric acid cycle (also 
known as TCA cycle) and oxidative phosphorylation (Moreno-Sánchez et al., 
2007).  
The first few steps of glucose catabolism are called glycolysis, which occur in the 
cytoplasm. Glucose is modified and decomposed by a series of steps, and 
eventually produces two pyruvate and two ATP molecules per glucose used. 
There are usually two outcomes for the resulting pyruvate: (1) in the absence of 
oxygen (as muscle cells under condition of anaerobic exercise) or absence of 
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mitochondrion (as in the red blood cells), the pyruvates are converted to two 
molecules of lactate by the lactate fermentation in the cytoplasm; (2) in the 
presence of both oxygen and mitochondrion, the pyruvates are shuttled to the 
mitochondrial matrix where they are cleaved to form acetyl-CoA. 
Then Acetyl-CoA enters the TCA cycle by reacting with oxaloacetate to produce 
citrate. Citrate is then in turn converted to isocitrate, α-ketoglutarate, succinate, 
fumarate, malate and back to oxaloacetate by a series of reactions, and this 
oxaloacetate is able to combine with another molecule of acetyl-CoA and 
initiating another cycle of reactions (Figure 1.1). Through each cycle, two 
molecules of nicotinamide adenine dinucleotide (NADH) and 1 molecule of flavin 
adenine dinucleotide (FADH2) are generated and fed into the electron transport 
chain as the electron donors (Wolfe and Jahoor, 1990). 
 
1.1.3 The Electron Transport Chain and Oxidative Phosphorylation 
The electron transport chain (ETC) passes electrons to the final electron 
acceptor oxygen, and simultaneously pump proton out of matrix to form 
membrane potential. ETC includes four major complexes that are embedded in 
the inner mitochondrial membrane. The cofactors NADH and FADH2 produced 
from the TCA cycle deliver their electrons to complex I and II, respectively, then 
the electrons are shuttled to mobile lipophillic carrier ubiquinone to complex III to 
cytochrome C to complex IV. The electrons reduce molecular oxygen at complex 
IV and produce water in the matrix. Meanwhile, the passing of electrons leads 
complexes I, III and IV to actively pump 4, 2, and 4 protons respectively into the 
intermembrane space, contributing to the formation and maintenance of the 
proton gradient across the inner membrane (Rottenberg, 1975). This membrane 
potential provides the proton motive force that powers the ATP production. By 
passing protons
 
back into the matrix along the concentration gradient, the F1/F0 
ATP synthase, also known as complex V, utilizes this proton motive force to 






Figure 1.1  The Citric Acid Cycle. The Citric acid cycle Includes complicated 
enzymatic reactions during which 1 molecule of acetyl-CoA is consumed, while 2 












Figure 1.2   The Electron Transport Chain and Oxidative Phosphorylation. 
Cofactors NADH and FADH2 deliver electrons to complex I and complex II, which 
transfer the electrons to complex III through ubiquinone. From complex III the 
electrons are transferred to cytochrome c (Cyt. C) and finally to complex IV. At 
complex IV the electrons are oxidized by molecular oxygen and produce water. 
Meanwhile, the protons pumped out by complex I, II and IV are used to form the 








This is the process called oxidative phosphorylation (OXPHOS) (Figure 1.2) 
(Boyer, 1997; Schultz and Chan, 2001). 
 
1.2 Mitochondrial Respiratory Efficiency 
As previously mentioned, the oxidative phosphorylation is very efficient in 
generating ATP, producing 34 ATPs in the ideal situation. However, the proton 
leaking though the inner mitochondrial membrane uncouples the proton gradient 
from ATP synthesis. Namely, not every proton pumped into the intermembrane 
space is used for ATP production, which makes the ATP synthesis via OXPHOS 
less efficient,  
In the situation when the cell has abundant ATP, the ATP synthase will be 
inhibited by the high ATP/ADP ratio and slow down the ATP production. In turn, 
electron transport rate and therefore respiration slows, membrane potential is 
elevated, and the tendency of electrons to slip from complexes I,II and III is 
increased. Therefore, the reactive oxygen species (ROS) form when the escaped 
electrons attack O2 molecules and partially reduce them. 
To prevent the damages caused by ROS, mitochondrial membranes developed 
several mechanisms to leak protons, thereby decreasing the proton gradient and 
making oxygen consumption operate normally even in the absence of ATP 
production (Brand and Esteves, 2005). This process is termed respiratory 
uncoupling because it dissipates the proton gradient formed by the electron 
transport chain. As the result, the electron transport chain drives wasted cycles of 
proton pumping and proton leaking, and release the energy in the form of heat 
(Figure 1.3) (Cannon and Nedergaard, 2004).  
This basal proton leak is shown to be responsible for about 20-50% of the total 
cellular respiration rate in rat skeletal muscle and liver (Rolfe et al., 1999). This 
unexpectedly high uncoupling rate implies the importance of maintaining a 









Figure 1.3  The Mechanism of Respiratory Uncoupling. ANTs and UCPs 
mediate basal and induced respiratory uncoupling respectively. The mechanism 
of uncoupling is to dissipate the proton gradient formed by the electron transport 
chain and decrease membrane potential. Through this process, the proton 






chain, even without the energy demand to produce ATP.  
There are several mechanisms responsible for the respiratory uncoupling 
processes under different conditions. For the basal proton leak mentioned above, 
a small proportion is due to the diffusion across the mitochondrial membranes, 
and the majority of basal proton conductance (~64%) is conducted by the 
adenine nucleotide translocase (ANT) (Brand and Esteves, 2005; Parker et al., 
2008). ANTs are a group of Mitochondrial Carrier proteins localized in the inner 
mitochondrial membrane. Their main function is to use the proton motive force 
export ATP from the matrix in trade for cytoplasmic. In addition to the basal 
proton conductance, mitochondria also have an inducible proton leak route 
mediated through the uncoupling proteins (UCPs), which promote around 11% of 
the uncoupling in mammalian tissues (Parker et al., 2008). Studies using UCP-
knockout mice have shown that UCPs are not responsible for the basal proton 
leak across the inner mitochondrial membranes (Brand and Esteves, 2005). On 
the contrary, their activity can be activated or inhibited by some common 
metabolites in the mitochondrial environment, enabling UCPs to respond quickly 
to the changes in the metabolic level in mitochondria.  
 
1.3 Mitochondrial Uncoupling Proteins 
Uncoupling proteins are evolutionarily conserved carrier proteins that belong to 
the mitochondrial solute carrier superfamily (SLC25) of transporters. All SLC25 
transporters are nuclear-encoded and localized to the inner mitochondrial 
membrane, responsible for transporting various solutes between the 
mitochondrial matrix and cytoplasm. The members of the SLC25 family are very 
similar in structure. They all contain six trans-membrane domains, with the N- 
and C-termini in the intermembrane space (Figure 1.4) (Maloney, 1990). They 
are also predicted to have FA binding domains, nucleotide binding domains, and 








Figure 1.4 Domain Structures of UCPs and other SLC25 Family Proteins. 
The SLC25 family proteins are localized in the inner mitochondrial membrane. All 









members identified to date, including the ANTs, another group of proteins 
mediating proton leak mentioned in the previous section.  
The UCPs comprise the largest subfamily of SLC25. This subfamily includes five 
identified trans-membrane anion-carrier proteins (UCP1-5), each having distinct 
physiological implications and expression patterns (Krauss et al., 2005). Their 
roles are generally associated with regulation of proton conductance across the 
inner mitochondrial membrane and maintaining the normal level of mitochondrial 
respiration. As opposed to the basal proton leak, the uncoupling mediated by 
UCPs is inducible but strongly inhibited. UCPs are strongly inhibited by purine 
nucleotides (including ADP and GDP), which bind at the intermembrane side of 
UCPs (Echtay et al., 2003; Jabůrek and Garlid, 2003). Meanwhile, several 
activators of UCPs have been identified, although the mechanism how these 
molecules regulate UCPs is still unclear. The most common type is medium to 
short-chain fatty acids, including lauric, palmitic, capric, oleic, and linoleic acids 
(Jabůrek and Garlid, 2003; Ježek et al., 1997). The binding of fatty acid with UCP 
induces conformational changes that can mask the nucleotide-binding domains, 
and therefore overcome the inhibition by the nucleotides (Huang, 2003). In 
addition to fatty acids, superoxide (O2-) and lipid peroxides that produced from 
oxidation of FFAs are also able to activate UCPs through covalent modification 
(Echtay et al., 2002, 2003; Esteves and Brand, 2005; Talbot et al., 2003, 2004).  
The biochemical mechanism by which UCPs mediate uncoupling is still under 
debate. A few mechanisms have been hypothesized, but by far no conclusion is 
reached (Figure 1.5). One model is that UCPs directly transport protons from the 
inner membrane space to the matrix and use fatty acids as cofactors to facilitate 
the proton leak (Garlid et al., 1998; Klingenberg and Huang, 1999). The second 
model is that UCPs act as OH- uniporter, which is allosterically activated by fatty-
acid (Nicholls, 2006). The third model is referred as “fatty-acid cycling” model, in 
which UCPs act as antiporters for protonated/unprotonated fatty acids and 
transport protons indirectly. In this process, fatty acids are protonated in the more 







Figure 1.5  The Proposed Models of UCP-mediated Proton Leak. There are 
three theories about this process: (1) suggests UCP directly translocate proton 
into the matrix as an uniporter; (2) suggests UCP transport hydroxyl group out of 
the matrix, which is electrochemically equivalent to importing a proton; (3) 
suggests UCP transport fatty acid anion out of the matrix, where the anion gets 
protonated and then transported back into the matrix, then the proton dissociates 
from the fatty acid. Through this “fatty acid cycling” model, the proton is 






translocated into intermembrane space again. In this model, the uncoupling 
protein facilitates the exchange of one protonated fatty acid for one unprotonated 
fatty acid, resulting in leaking of proton into matrix without changing fatty acid 
level on either side (Ježek et al., 1998; Porter, 2008). 
In summary, all UCPs facilitate proton leak back into the matrix, thereby lowering 
the mitochondrial membrane potential generated by ETC. This process 
uncouples the electron transport from ATP production, which means it drives 
electron transport and oxygen consumption without ATP synthesis, and releases 
the energy as heat. 
 
1.3.1 Uncoupling Protein 1  
UCP1 is the first member discovered in the UCP family, and is well-known for its 
role in brown adipose tissue (BAT) thermogenesis. BAT is a distinct type of 
adipose tissue from the more commonly found white adipose tissue (WAT). 
Compared with the simple fatty-acid-storage function of WAT, BAT has a more 
energy-demanding role – maintaining the body temperature, especially in 
neonates and hibernating animal (Smith and Horwitz, 1969). The structural and 
functional analysis of BAT demonstrated that BAT contains a much higher 
amount of mitochondria, and the mitochondria isolated from BAT exhibited an 
unexpectedly high level of respiration (Hittelman et al., 1969; Smith and Horwitz, 
1969). 
UCP1 was first identified in isolated mitochondria from BAT in 1970’s, and the 
excessively high respiratory capacity of BAT is attributed to UCP1 (Bouillaud et 
al., 1985; Cannon et al., 1982; Nicholls, 1976). Numerous investigations have 
been performed since its discovery, and have gained remarkable insight in 
respect of its expression pattern, function and regulation. 
UCP1 is traditionally believed to express exclusively in BAT of rodents, infant 
humans and hibernating mammals. However, BAT depots are recently identified 
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in adult humans, and UCP1, as the identifying marker of BAT, is also present 
(Nedergaard et al., 2007). UCP1 is much more abundantly expressed in BAT 
than any other UCPs, accounting for up to 10% of the mitochondrial protein 
expression (Nicholls, 1976).  Consequently, it is considered the primary 
uncoupling protein in BAT, where its effect cannot be masked by other homologs 
(Cannon and Nedergaard, 2004; Parker et al., 2009). 
UCP1 has been shown to dissipate the proton gradient across the mitochondrial 
inner membrane and increased heat production in mitochondrial matrix. Because 
of its uncoupling properties, UCP1 is implicated in the regulation of respiration 
and diet-induced thermogenesis. Genetic inactivation of UCP1 in mice results in 
the defective cold-induced thermogenesis, confirming the physiological role of 
UCP1 in BAT thermogenesis (Enerbäck et al., 1997; Feldmann et al., 2009). But 
whether UCP1 is associated with body weight regulation is still unclear, due to 
conflicting experimental results (Nedergaard et al., 2007). 
As a prototypical UCP, the activity of UCP1 is strongly inhibited by purine 
nucleotides at physiological level and activated by free fatty acid (Huang, 2003; 
Nicholls, 1976). At the histological level, UCP1 is tightly regulated by stimuli such 
as diet and cold stress. Under these conditions, the adrenergic receptors on the 
cell surface are activated and result in increased cellular free fatty-acid level, 
which will activate UCP1 mediated proton conductance within minutes (Klaus et 
al., 2001; Rodriguez-Cuenca et al., 2002). 
 
1.3.2 Uncoupling Protein Homologs 
The uncoupling proteins are a subfamily of the mitochondrial solute carrier 
proteins that have been found in fungi, plants, protists, insects, nematodes, flies, 
and vertebrates (Iser et al., 2005; Ježek et al., 1996; Sanchez-Blanco et al., 
2006). Since the discovery of UCP1 in 1976, other homologs have been 
identified based upon their protein sequences (UCP1-5). Though extensive 
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researches have been performed on these homologs, UCP1 is by far the only 
UCP that has a well-established physiological function. All these homologs have 
distinct expression patterns, and have been involved with various tissue-specific 
physiological roles. 
 
UCP2 was first identified in 1997 and is ubiquitously expressed in mammalian 
tissues at varing levels (Fleury et al., 1997; Mattiasson and Sullivan, 2006). 
Although it has the highest sequence homology (59%) to UCP1, it is functionally 
distinguishable from UCP1 (Fleury et al., 1997). Unlike UCP1, genetic ablation of 
UCP2 in mice has not affected the cold-induced thermoregulatory capacity 
(Matthias et al., 2000). However, UCP2 has shown a more indirect function in 
thermoregulation by increasing the sensitivity of the nervous system to the 
thermoregulatory hormone triiodothyronine (Coppola et al., 2007; Zaretskaia et 
al., 2002). UCP2 also plays a physiologically important role in regulating the 
glucose-stimulated insulin secretion and defending against type-2 diabetes. The 
pancreatic β-cells can detect the blood glucose level and secret insulin when its 
concentration is high. In this process, the cellular ATP/ADP ratio acts as the 
indicator of the blood glucose level (Rutter, 2001). Through its uncoupling 
function, UCP2 dissipate the proton gradient formed by ETC and decreases ATP 
production derived from glucose metabolism. Thus, UCP2 maintains a relatively 
low ATP/ADP ratio in β-cells and negatively regulates insulin secretion (Chan et 
al., 1999, 2001; Zhang et al., 2001). This model is supported by genetic 
engineering of UCP2 in animal and cell line. When overexpressed, UCP2 further 
attenuates glucose-stimulated insulin secretion in pancreatic β-cells (Li et al., 
2001). But the UCP2 knockout mice showed significantly increased insulin 
secretion from pancreatic islets (Zhang et al., 2001). 
 
UCP3, the focus of this thesis, is also identified in 1997. UCP3 also shows high 
sequence homology (57%) to UCP1, but their expression patterns are vastly 
different (Boss et al., 1997). UCP3 is primarily expressed in skeletal muscle and 
to a lesser degree in heart and BAT (Boss et al., 1998; 2000; Vidal-Puig et al., 
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1997; Clapham et al., 2000). Most recently, UCP3 has been found in human 
pancreatic islets (Li et al., 2008) and human skin (Mori et al., 2008). UCP3 
shares conserved structure with UCP1, including the domains responsible for 
proton leak and nucleotide binding. Thus, UCP3 is speculated to have similar 
roles as UCP1. However, in addition to thermogenesis, different biological 
processes have been associated with UCP3, including insulin secretion, redox 
regulation, fatty-acid transport and metabolism, but no consensus has been 
reached to date. These will be discussed in later sections. 
 
Compared to UCP1-3, relatively little is known about the neuronal UCPs, UCP4 
and UCP5. Comparative analysis of amino acid sequences shows that UCP4 
and UCP5 share the least sequence homology (~31%) with UCP1, and has been 
postulated to act through different biochemical mechanisms, rather than the 
classical uncoupling function (Mattson and Liu, 2003; Palmieri, 2004). 
UCP4 is expressed in nearly all areas of the brain, and at low levels in the spinal 
cord (Mao et al., 1999). The expression of UCP4 in brain is developmentally 
regulated, as the level of UCP4 is elevated along with neuronal differentiation 
(Smorodchenko et al., 2009). Statistical study has also implied an involvement of 
UCP4 with the etiology of schizophrenia (Yasuno et al., 2007). These results 
indicate that UCP4 has a specific function in neuronal development. Besides, 
ceUCP4, which is highly similar with hUCP4, has shown a novel biochemical 
function in regulating mitochondrial succinate import (Pfeiffer et al., 2011). In this 
way, it is able to regulate the mitochondrial respiration and glucose metabolism 
without changes in the uncoupling level. UCP4-5 share the same inhibitors 
(purine nucleotides) as mammalian UCP1-3, but are not responsive to the 
common activating agent of UCPs, the free fatty acid (Ivanova et al., 2010; 
Jabůrek and Garlid, 2003). Comparative sequence analysis revealed that UCP4 
lacks several key residues responsible for FA binding and proton transport 
(Robinson et al., 2008). This again implies that UCP4 may not function as a 
classical uncoupler. However, UCP4 still retains at least part of the classical 
uncoupling functions, as the overexpression of UCP4 in neural cells has been 
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demonstrated to decrease the membrane potential, reduce reactive oxygen 
species level and decrease mitochondrial calcium accumulation (Liu et al., 2006). 
Since the brain has a high-metabolic demand and highly relies on glucose as the 
energy source, it is likely that UCP4 serves as an important regulatory protein 
under conditions of metabolic and oxidative stress. Moreover, Mutations in UCP4 
have been related to the aging-associated diseases, such as Alzheimer’s 
disease and Parkinson’s disease, confirming the importance of UCP4 in 
protecting the brain against the oxidative stress (Wu et al., 2009). Since Ca2+ 
acts as an key secondary messenger in controlling oxidative phosphorylation and 
apoptosis, the ability of UCP4 to regulate Ca2+
 
accumulation in mitochondria via 
reducing membrane potential is also physiologically crucial.  
UCP5, also known as brain mitochondrial carrier protein-1 (BMCP1), is 
expressed in specific brain regions such as the cortex, hippocampus, and 
thalamus (Kim-Han et al., 2001; Sanchis et al., 1998). Very little is known 
concerning UCP5 function, but it has been observed to function as a prototypical 
uncoupling protein and decrease membrane potential (Yu et al., 2000). This 
mechanism implicates its ability to decrease ROS production in the brain. 
Recently, a UCP5 homolog in Drosophila was identified to be related to energy 
homeostasis and aging (Sanchez-Blanco et al., 2006). 
 
1.3.3 Uncoupling Protein 3 
When UCP3 was first identified in 1997, it was found to have has high sequence 
homology and structural resemblance to UCP1. Considering it is expressed 
mainly in the highly thermogenic and metabolic tissues (skeletal muscle, brown 
adipose tissue, and heart), UCP3 is speculated to have the same thermogenic 
function as UCP1 (Boss et al., 1997). Several studies support this model, as 
increased UCP3 expression has been observed in response to cold exposure, 
and absence of UCP3 leads to abolished drug-induced hyperthermia (Larkin et 
al., 1997; Mills et al., 2003). However, there is also evidence against this model. 
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The identification of UCP homologs in ectotherms such as fish and plant seems 
to imply UCPs have some different and more general function (Laloi et al., 1997; 
Stuart et al., 1999). Moreover, UCP3-deficient mice showed normal cold-induced 
thermogenesis, although decreased muscle proton leak was observed 
(Golozoubova et al., 2001; Gong et al., 1997). Thus, although the exact functions 
of UCP3 mediated are still unclear, it is a consensus that the thermogenesis is 
not the primary role of UCP3.  
The biochemical functions of UCP3 have been investigated in numerous studies. 
One of the most well-known models proposed is the mitigation of oxidative 
stress. This function has been confirmed by the In vivo study that showed 
decreased ROS-induced protein damage in skeletal muscle when UCP3 was 
overexpressed (Barreiro et al., 2009). As previously mentioned, ROS forms when 
the electron transport chain slows down and electrons slip away from ETC. ROS 
are generally believed to be toxic as they can damage proteins, DNA, and lipids, 
and have been connected to many diseases. The model hypothesizes that: Since 
UCP1-3 can be activated by superoxide as previously mentioned, the 
accumulation of ROS can promote UCP3 to drive the electron transport and 
oxygen consumption, and in turn reduce ROS production (Figure 1.6). As the 
uncoupling function is common for the whole UCP family, this role in redox 
regulation has also been observed from all other UCPs (Korshunov et al., 1997). 
Another ROS scavenging protein, thioredoxin 2 (Trx2) has been identified as a 
direct interaction partner of UCP3, and facilitates the UCP3-dependent 
suppression of ROS production (Hirasaka et al., 2011). 
The second proposed function of UCP3 is the regulation of insulin secretion in 
pancreatic islet cells. Insulin resistance in skeletal muscle is the major cause of 
Type 2 diabetes mellitus (T2DM), the most common form of diabetes (Chan and 
Harper, 2006). Evidence supporting the function of UCP3 in ameliorating insulin 
resistance comes from studies showing that mice overexpressing UCP3 in 
skeletal muscle are protected from obesity and insulin resistance (Choi et al., 








Figure 1.6  The Mechanism of UCP3-mediated ROS Suppression. When 
protons accumulate in the intermembrane space, ETC slows down and electrons 
slip away from complex I, II and III to attack molecule oxygen. The molecule 
oxygen gets partially reduced and form superoxide, which can activate UCP3. 
Once activated, UCP3 dissipates the proton gradients and reduces membrane 
potential. This drives the electron transport and prevents electrons from slipping 







UCP3 is proposed by Li et al, who identified UCP3 in pancreatic islet cells and 
found it to participate in insulin secretion regulation (Li et al., 2008).  
Besides, the role of UCP3 in the regulation of fatty acid metabolism and transport 
also seems important to the prevention of obesity and diabetes. Studies have 
demonstrated involvement of UCP3 in nonesterified fatty acids transport from the 
mitochondrial matrix into the intermembrane space (Schrauwen et al., 2001, 
2006). As the accumulation of fatty acid can activate UCP3, this function is 
believed to prevent lipotoxicity by exporting the excess fatty acids and facilitate β-
oxidation and the TCA cycle by liberating coenzyme A (Himms-Hagen and 
Harper, 2001). The animal model supports this mechanism as overexpression of 
UCP3 in mice has shown increased level of fatty acid transport and 
oxidation(Bézaire et al., 2007; Bezaire et al., 2005). Our lab has proposed 
another mechanism by which UCP3 regulate fatty acid metabolism. UCP3 is 
shown to directly bind ∆3,5∆2,4dienoyl-CoA isomerase (DCI), an auxiliary fatty acid 
oxidation enzyme specifically for unsaturated fatty acid with odd-numbered 
double bond, such as linoleic, linolenic  and oleic acid. Without DCI, these 
unsaturated fatty acids cannot be oxidized and will accumulate in mitochondrial 
as toxic lipid metabolites. The interaction between UCP3 and DCI has been 
proven to promote the oxidation of these acids (unpublished).   
Other functions are less discussed but have also been proposed. One of the 
models is the function of UCP3 in regulating mitochondrial Ca2+
 
uniport, the key 
regulator of apoptosis (Graier et al., 2008). In this model, UCP3 is believed to 
mediate Ca2+ import independent of Ψ, which indicates UCP3 may catalyze 
additional biochemical reaction other than proton leak (Trenker et al., 2007).  
More recently, another study has shown that UCP3 can drive cell differentiation 
and oppose cancer development in mouse keratinocytes through unclear 
mechanisms (Lago et al., 2012). 
In summary, although all these different functions of UCP3 have been proposed 
and debated, no conclusion is reached to date.  
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1.4 UCP3 and DNA methylation 
Epigenetics defined as heritable changes in gene expression that occur without 
changes in DNA sequence (Li et al., 2005). It generally refers to DNA methylation 
and histone modifications (including phosphorylation, acetylation, methylation, 
ubiquitylation etc.), which are recently revealed to be interdependent and 
bidirectionally crosstalking (Cedar and Bergman, 2009). DNA methylation is 
traditionally believed to be stable against environmental factors. However, 
dynamic methylation changes are later found to be associated with various 
diseases, environmental stresses, and even exercise (Barrès et al., 2012; Weber 
et al., 2005). The most typical aberrations of DNA methylation occur at 5-carbon 
of cytosine in CpG islands, which is catalyzed by DNA methyltransferases 
(DNMT). In mammalian cells, three DNMTs exist to mediate CpG 
hypermethylation: DNMT1 maintains the large degree of global DNA methylation, 
whereas DNMT3A and DNMT3B are de novo methylases that are responsible for 
the dynamic methylation (Li, 2002). 
Previous researches have shown quite some examples that dysfunctional 
mitochondrial respiration abolishes the balance of epigenetic control.  Some 
metabolites accumulated during defective TCA cycle, including the 2-
hydroxyglutarate, succinate and fumarate, have shown specific inhibitory effects 
on enzymes mediating DNA demethylation and histone demethylation (Cervera 
et al., 2009; Chowdhury et al., 2011; Figueroa et al., 2010; Turcan et al., 2012; 
Xiao et al., 2012; Xu et al., 2011). Moreover, the absence of mitochondrial DNA 
has been shown to significantly induce DNA methyltransferase 1 and result in 
global hypermethylation of the genomic DNA (Xie et al., 2007).  
By far, there are very few researches investigating the relationship between 
UCPs and Epigenetics, except one study showing that UCP1 is regulated by 
histone demethylase Jhdm2a (Tateishi et al., 2009). However, many diseases 
that UCP3 defend against, including cancer, obesity and type II diabetes, are 
tightly coupled with altered metabolism and methylation-dependent silencing 
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of specific genes. In addition, normal mitochondrial metabolism is required for 
the maintenance of normal epigenetic processes. Considering the crucial 
function of UCP3 in driving the electron transport and mitochondrial respiration, 
as well as in suppressing ROS generation and facilitating fatty acid oxidation, the 
absence of UCP3 may lead to dysregulated epigenetics, and consequently 
various diseases. 
Given the role of UCP3 in relieving oxidative stress, reactive oxygen species 
provide a potential link between UCP3 and epigenetics. ROS have been shown 
to play opposite roles in inducing both DNA hypermethylation and 
hypomethylation (Donkena et al., 2010). On one side, ROS has been found to 
alter DNA methylation by oxidizing DNMTs or through direct oxidation of 
nucleotide. Additionally, the cofactor S-adenosyl methionine (SAM), which is the 
methyl donor for DNA methylation and histone methylation, is also dependent on 
the glutathione metabolism. When glutathione is depleted by ROS, methyl 
donors become deficient, resulting in genome-wide DNA hypomethylation 
(Hitchler and Domann, 2009; Naviaux, 2008). On the other side, ROS-induced 
DNA hypermethylation of promoter CpG islands is a very frequent mechanism for 
gene expression inhibition, and is frequently seen in tumors (Quan et al., 2011). 
Previous studies have shown the ability of ROS to induce gene promoter 
hypermethylation by enhancing DNMT expression, activity and recruitment to the 
promoter regions (He et al., 2012; Kang et al., 2012; Lim et al., 2008). 
The only experiment trying to investigate the connection between proton leak and 
DNA methylation is performed using FCCP, a chemical uncoupler. Unfortunately, 
the cell cannot survive long enough with FCCP treatment, and they failed to 
observe a change in methylation level (Xie et al., 2007). However, the model that 
DNA methylation is affected by mitochondrial respiratory uncoupling is still 
plausible and requires further investigation.  
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1.5 Concluding Remark 
Mitochondrial uncoupling proteins are the principle mediator of inducible proton 
leak in various tissues. The prototypical UCPs can increase mitochondrial 
respiration by driving the flux of electron transport and promoting the reduction of 
oxygen. Due to the importance of respiration and glucose metabolism in all 
organisms, UCPs are speculated to have crucial roles in keeping the energy 
balance and mitochondrial metabolism. Among the members in the UCP family, 
only UCP1 has a well-established function in maintaining body temperature. All 
the other UCPs (UCP2-5) are still in mystery. UCP3 has been implicated in ROS 
mitigation, fatty acid export, and calcium uptake, but no conclusive answer has 
been widely accepted. 
Several proteins have been found to interact with UCP3 and facilitate different 
UCP3 functions, while more protein-protein interactions involving UCP3 have 
been observed but need to be confirmed by biochemical approaches. Based on 
these results, our hypothesis is that UCP3 form a well-organized multi-protein 
complex with different proteins, and carry out more roles than simply mediate 
respiratory uncoupling. To prove this hypothesis, we need a more 
comprehensive profile of proteins interacting with UCP3, the interaction 
landscape of UCP3 complex. We used the proteomic approach – affinity 
purification followed by mass spectrometry (AP-MS). Compared to the traditional 
approach such as yeast two-hybrid, mass spectrometry is more sensitive, time-
efficient, quantitative and the is able to detect indirect protein-protein interaction.  
Another goal of this investigation was to study the effect of UCP3 on genome-
wide DNA methylation. Defective metabolism is one of the leading causes of 
uncontrolled epigenetic changes. Consequently, the UCP3 may have an indirect 
role in epigenetic regulation by maintaining normal mitochondrial respiration. Our 
hypothesis is that UCP3-deficient animals should show a significant difference in 
global methylation level compared to wild-type animal. And we conducted a pilot 
study to verify this hypothesis. 
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In summary, mitochondrial uncoupling proteins play a pivotal role in the 
regulation of mitochondrial respiration. Dysregulation of these proteins can cause 
an array of different disease states. Our study will contribute to the understanding 
of UCP3 function, and may provide certain insights in prevention and therapies 


















Chapter 2 methods and materials 
 
2.1 Chemicals and Reagents 
Unless otherwise stated, all reagents and chemicals were obtained from Sigma- 
Aldrich (St. Louis, MO). 
 
2.2 Animals 
C57BL/6J mice, C57BL/6J UCP3 -/- mice and C57BL/6J-hUCP3-α1actin-SKM- 
TG+/+ mice were maintained on standard laboratory chow and a 12 hour 
light/dark cycle at room temperature. All procedures were approved by the 
University of Texas Institutional Animal Care and Use Committee (IACUC). 
 
2.3 Isolation of Muscle Tissues 
Mice were sacrificed via CO2 asphyxiation and cervical dislocation. In mass 
spectrometry experiment, tibialis anterior, gastrocnemius, soleus, biceps, triceps, 
and pectoralis muscles were dissected and placed in ice-cold mitochondrial 
isolation buffer #1(100mM KCl, 500mM Tris-HCl, 2mM EGTA, pH 7.4). In DNA 
methylation experiment, gastrocnemius and soleus were dissected and flash 
freezed in liquid nitrogen and stored at -80 ̊ C until processing. 
 
2.4 Isolation of Mitochondria 
Mitochondria were isolated from muscle tissues. Tissues were finely minced in 
ice-cold mitochondrial isolation buffer #1 and centrifuged at 500g to remove the 
residual fat. Then tissues were re-suspended in 50ml complete mitochondrial 
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isolation buffer #2 (100mM KCl, 500mM Tris-HCl, 2mM EGTA, 1mM ATP, 5mM 
MgCl2, 0.5% BSA, pH 7.4) then transferred to a 30mL glass teflon homogenizer. 
After 30 strokes, the homogenates were centrifuged at 500g then applied to a 
70μm cell strainer to clear supernatant. The supernatant was then centrifuged at 
10,500 x g for 10min to pellet the mitochondria. Once isolated, mitochondrial 
pellets were resuspended in 800ul Immunoprecipitation buffer (50mM Tris-HCL, 
pH 7.5, 150mM NaCl, 1% Triton X-100 and protease inhibitors) using Bead Mill 
for 10 minutes. 
 
2.5 Quantification of Mitochondrial Protein Levels 
Mitochondrial protein levels were measured using the BCA Protein Assay Kit 
according to manufacturer’s instructions (Pierce, Rockford, IL). 
 
2.6  Immunoprecipitation 
Protein lysates were prepared in 600 μl of immunoprecipitation buffer. Samples 
were incubated with either 12μg of rabbit anti-UCP3 antibody at 4°C for 12 hours 
with rotation. Protein A/G Sepharose beads (60μL) were added to each sample 
and then rotated for 5 hours at 4°C. Beads were then burned in 35ul high-
stringency protein gel loading buffer. Supernatant was collected and run on Bio-
Rad precast gel. 
 
2.7 Mass Spectrometry 
The coomassie stained gel was submitted to The University of Texas at Austin 
ICMB Core Facility, where the LC-MS/MS was operated. The results were 
viewed via software Scaffold 3 developed by Proteome Software, Inc.  
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2.8 Isolation of Genomic DNA from Muscle Tissues 
20-30mg of muscle tissues was used for each reaction. The genomic DNA was 
isolated using Wizard® Genomic DNA Purification Kit according to 
manufacturer’s instruction (Promega). 
 
2.9 Quantification of Global DNA Methylation Level 
200ng of genomic DNA was used for each reaction. The DNA methylation level 
was quantified using Imprint® Methylated DNA Quantification kit (Sigma-Aldrich, 
St. Louis, MO). 
 
2.10 Statistics 
Statistical evaluation of the data was performed using the student’s t-test with 
significance level p<0.05. For all histograms, data are presented as averages 
with error bars representing standard error of the mean (SEM) from at least 3 
independent experiments. Single factor analysis of variance (ANOVA) was 
performed to determine the difference between the means of the three groups 








Chapter 3 Identification of Proteins Interaction Partners of UCP3 
 
3.1 Introduction 
Mitochondrial uncoupling proteins (UCP) mediate the proton leak across the 
inner mitochondrial membrane and thereby control the efficiency of OXPHOS. 
Proton leak dissipates the mitochondrial membrane potential and uncouple 
proton motive force from ATP synthesis. To date, five UCPs(UCP1-5) have been 
identified in mammals with distinct expression pattern. The prototype UCP1, 
expressed in brown adipose tissue, has the well-established physiological role in 
mediating cold-induced thermogenesis in rodents and human neonates 
(Enerbäck et al., 1997). Relative to UCP1, the roles of UCP2-5 in metabolism are 
less clear. 
UCP3 is primarily expressed in skeletal muscle, brown adipose tissue (BAT) and 
heart, all of which are highly metabolic and thermogenic tissues in humans (Boss 
et al., 1997; Gong et al., 1997). The expression level of UCP3 in skeletal muscle 
is relatively low - only 0.1%-1% as much as UCP1 in BAT. But considering the 
huge mass of skeletal muscle and its contribution to metabolic rate, UCP3 is still 
believed to play a pivotal role in metabolism. 
UCP3 have been demonstrated to regulate the transport of fatty acid anions, 
protons and calcium across the inner mitochondrial membrane, and 
consequently mitigate ROS generation (Fedorenko et al., 2012). However, the 
biochemical mechanisms underlying UCP3-regulated solute transport and proton 
leak are intensely debated. 
Several proteins have been identified to interact with UCP3 and facilitate different 
aspects of UCP3 functions. However, the identification of more interaction 
partners is necessary for further understanding the biochemical mechanism of 
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respiratory uncoupling and regulatory pathway of UCP3. 
The traditional approach to study protein-protein interactions is yeast two-hybrid, 
which generally takes two to three months and has a high false-positive rate. 
Moreover, yeast two-hybrid is not able to detect indirect interaction between two 
proteins. Nowadays, the advent of the highly sensitive MS-based protein 
identification methods significantly enhances the efficiency of research. The 
availability of proteomic sequence database and the development of 
bioinformatics algorithm further automatize the protein identification process, 
allowing us to find the proteomic protein network easily and rapidly. Here, we 
used the proteomic approach – affinity purification followed by mass 
spectrometry, which gave us a comprehensive list of all mitochondrial proteins 
that potentially interact with UCP3. These target proteins can shed light on the 
future researches in defining novel mechanisms of UCP3. 
 
3.2 Result 
The complete list of proteins interacting with UCP3 is displayed in Table 3.1. All 
the peptide sequences are aligned with NCBI protein sequence databases and 
protein identity are accurate with probability >95%.  The peak numbers represent 
how many times this specific protein has been identified, and hence semi-
quantitatively though not accurately exhibit the amount of protein immune-
precipitated along with UCP3.  
In this list, we were able to observe a relatively high number of UCP3 peaks (42 
peaks) in mitochondria isolated from UCP3 wild-type mice. This suggests the 
immune-precipitation experiment was able to successfully pull down detectable 
amount of UCP3. In contrast, there was no UCP3 peak identified in mitochondria 
of UCP3 knock-out mice (control group), which suggests the high peak number 
of UCP3 in wild-type mice is not due to contamination during the experiment. 
We have successfully identified around 170 target proteins as direct or indirect 
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binding partner of UCP3. Among them, we are able to observe some proteins 
exhibiting significant difference between the experimental group and the control 
group, which are less possible to be false-positives due to non-specific protein-
protein interaction. We set an arbitrary criterion: the proteins whose peak number 
is two-fold or higher in the wild-type group than the knock-out group are regarded 





Table 3.1 The Complete List of Protein-Protein Interactions of UCP3 








Stress-70 protein, mitochondrial OS=Mus musculus 
GN=Hspa9 PE=1 SV=3 
sp|P38647|GRP75_
MOUSE 73 kDa 137 166 
2 
ATP synthase subunit alpha, mitochondrial OS=Mus 
musculus GN=Atp5a1 PE=1 SV=1 
sp|Q03265|ATPA_M
OUSE 60 kDa 149 73 
3 
ATP synthase subunit beta, mitochondrial OS=Mus 
musculus GN=Atp5b PE=1 SV=2 
sp|P56480|ATPB_M
OUSE 56 kDa 117 106 
4 
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 
OS=Mus musculus GN=Atp2a1 PE=2 SV=1 
sp|Q8R429|AT2A1_
MOUSE 109 kDa 139 71 
5 
Rho guanine nucleotide exchange factor 10-like protein 
(Fragment) OS=Mus musculus GN=Arhgef10l PE=4 SV=1 
tr|F6ZH54|F6ZH54_
MOUSE-R ? 37 0 
6 
Aconitate hydratase, mitochondrial OS=Mus musculus 
GN=Aco2 PE=1 SV=1 
sp|Q99KI0|ACON_M
OUSE 85 kDa 82 22 
7 
ADP/ATP translocase 1 OS=Mus musculus GN=Slc25a4 
PE=1 SV=4 
sp|P48962|ADT1_M
OUSE 33 kDa 50 29 
8 
Histone H1.2 OS=Mus musculus GN=Hist1h1c PE=1 
SV=2 
sp|P15864|H12_MO
USE 21 kDa 26 33 
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Table 3.1 The Complete List of Protein-Protein Interactions of UCP3 (Con’t) 
9 
Isocitrate dehydrogenase 3 (NAD+) beta OS=Mus 
musculus GN=Idh3b PE=2 SV=1 
tr|Q91VA7|Q91VA7_
MOUSE 42 kDa 38 21 
10 
Dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex, mitochondrial OS=Mus 
musculus GN=Dlat PE=1 SV=2 
sp|Q8BMF4|ODP2_
MOUSE 68 kDa 29 25 
11 
Very long-chain specific acyl-CoA dehydrogenase, 
mitochondrial OS=Mus musculus GN=Acadvl PE=1 SV=3 
sp|P50544|ACADV_
MOUSE 71 kDa 45 8 
12 
Myosin-binding protein C, fast-type OS=Mus musculus 
GN=Mybpc2 PE=1 SV=1 
sp|Q5XKE0|MYPC2
_MOUSE 127 kDa 15 34 
13 
Mitochondrial uncoupling protein 3 OS=Mus musculus 
GN=Ucp3 PE=2 SV=1 
sp|P56501|UCP3_M
OUSE 34 kDa 42 0 
14 
78 kDa glucose-regulated protein OS=Mus musculus 
GN=Hspa5 PE=1 SV=3 
sp|P20029|GRP78_
MOUSE 72 kDa 16 25 
15 
Succinate dehydrogenase [ubiquinone] flavoprotein 
subunit, mitochondrial OS=Mus musculus GN=Sdha PE=1 
SV=1 
sp|Q8K2B3|DHSA_
MOUSE 73 kDa 28 12 
16 
Calsequestrin-1 OS=Mus musculus GN=Casq1 PE=2 
SV=3 
sp|O09165|CASQ1_




Table 3.1 The Complete List of Protein-Protein Interactions of UCP3 (Con’t) 
17 
Heat shock cognate 71 kDa protein OS=Mus musculus 
GN=Hspa8 PE=1 SV=1 
sp|P63017|HSP7C_
MOUSE 71 kDa 9 28 
18 
Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial OS=Mus musculus GN=Idh3a PE=1 SV=1 
sp|Q9D6R2|IDH3A_
MOUSE 40 kDa 22 17 
19 
Pyruvate dehydrogenase E1 component subunit beta, 
mitochondrial OS=Mus musculus GN=Pdhb PE=1 SV=1 
sp|Q9D051|ODPB_
MOUSE 39 kDa 23 13 
20 
3-ketoacyl-CoA thiolase, mitochondrial OS=Mus musculus 
GN=Acaa2 PE=1 SV=3 
sp|Q8BWT1|THIM_
MOUSE 42 kDa 23 13 
21 




(+3) 57 kDa 8 9 
22 
Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, 
mitochondrial OS=Mus musculus GN=Sdhb PE=1 SV=1 
sp|Q9CQA3|DHSB_
MOUSE 32 kDa 12 17 
23 
Succinyl-CoA ligase [ADP-forming] subunit beta, 
mitochondrial OS=Mus musculus GN=Sucla2 PE=1 SV=2 
sp|Q9Z2I9|SUCB1_
MOUSE 50 kDa 28 4 
24 
Complement C1q subcomponent subunit A OS=Mus 
musculus GN=C1qa PE=1 SV=2 
sp|P98086|C1QA_M
OUSE 26 kDa 18 13 
25 Myosin-4 OS=Mus musculus GN=Myh4 PE=1 SV=1 
sp|Q5SX39|MYH4_
MOUSE 223 kDa 30 3 
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Table 3.1 The Complete List of Protein-Protein Interactions of UCP3 (Con’t) 
26 
Actin, alpha skeletal muscle OS=Mus musculus GN=Acta1 
PE=1 SV=1 
sp|P68134|ACTS_M
OUSE 42 kDa 18 9 
27 
Electron transfer flavoprotein subunit alpha, mitochondrial 
OS=Mus musculus GN=Etfa PE=1 SV=2 
sp|Q99LC5|ETFA_M
OUSE 35 kDa 19 11 
28 
Trifunctional enzyme subunit alpha, mitochondrial OS=Mus 
musculus GN=Hadha PE=1 SV=1 
sp|Q8BMS1|ECHA_
MOUSE 83 kDa 21 4 
29 Fibromodulin OS=Mus musculus GN=Fmod PE=2 SV=1 
sp|P50608|FMOD_
MOUSE 43 kDa 7 14 
30 Isoform 2 of Sarcalumenin OS=Mus musculus GN=Srl 
sp|Q7TQ48-
2|SRCA_MOUSE 
(+1) 54 kDa 15 11 
31 
Elongation factor Tu, mitochondrial OS=Mus musculus 
GN=Tufm PE=1 SV=1 
sp|Q8BFR5|EFTU_
MOUSE (+1) 50 kDa 20 5 
32 
Myosin-binding protein H OS=Mus musculus GN=Mybph 
PE=1 SV=2 
sp|P70402|MYBPH_
MOUSE 53 kDa 4 15 
33 
Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, 
mitochondrial OS=Mus musculus GN=Suclg1 PE=1 SV=4 
sp|Q9WUM5|SUCA_
MOUSE 36 kDa 16 8 
34 
Complement C1q subcomponent subunit B OS=Mus 
musculus GN=C1qb PE=1 SV=2 
sp|P14106|C1QB_M
OUSE 27 kDa 10 12 
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Table 3.1 The Complete List of Protein-Protein Interactions of UCP3 (Con’t) 
35 
Complement C1q subcomponent subunit C OS=Mus 
musculus GN=C1qc PE=2 SV=2 
sp|Q02105|C1QC_M
OUSE 26 kDa 11 9 
36 
Ryanodine receptor 1 OS=Mus musculus GN=Ryr1 PE=1 
SV=1 
sp|E9PZQ0|RYR1_
MOUSE (+1) 565 kDa 16 5 
37 
Glyceraldehyde-3-phosphate dehydrogenase OS=Mus 
musculus GN=Gapdh PE=1 SV=2 
sp|P16858|G3P_MO
USE 36 kDa 15 7 
38 
Pyruvate dehydrogenase E1 component subunit alpha, 
somatic form, mitochondrial OS=Mus musculus GN=Pdha1 
PE=1 SV=1 
sp|P35486|ODPA_M
OUSE 43 kDa 10 10 
39 
Glycerol-3-phosphate dehydrogenase, mitochondrial 
OS=Mus musculus GN=Gpd2 PE=1 SV=2 
sp|Q64521|GPDM_
MOUSE (+1) 81 kDa 14 5 
40 
Keratin, type II cytoskeletal 8 OS=Mus musculus GN=Krt8 
PE=1 SV=4 
sp|P11679|K2C8_M
OUSE 55 kDa 7 11 
41 
Myosin regulatory light chain 2, skeletal muscle isoform 
OS=Mus musculus GN=Mylpf PE=1 SV=3 
sp|P97457|MLRS_M
OUSE 19 kDa 8 9 
42 
Calcium-binding mitochondrial carrier protein Aralar1 
OS=Mus musculus GN=Slc25a12 PE=1 SV=1 
sp|Q8BH59|CMC1_
MOUSE 75 kDa 14 4 
43 Serum albumin OS=Mus musculus GN=Alb PE=1 SV=3 
sp|P07724|ALBU_M
OUSE 69 kDa 7 0 
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Table 3.1 The Complete List of Protein-Protein Interactions of UCP3 (Con’t) 
44 




(+1) 37 kDa 5 4 
45 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex 
subunit 4 OS=Mus musculus GN=Ndufa4 PE=1 SV=2 
sp|Q62425|NDUA4_
MOUSE 9 kDa 11 7 
46 
Tripartite motif-containing protein 72 OS=Mus musculus 
GN=Trim72 PE=1 SV=1 
sp|Q1XH17|TRI72_
MOUSE 53 kDa 13 3 
47 
Isoform 2 of 2-oxoglutarate dehydrogenase, mitochondrial 
OS=Mus musculus GN=Ogdh 
sp|Q60597-
2|ODO1_MOUSE 
(+3) 115 kDa 11 1 
48 
ATP synthase subunit O, mitochondrial OS=Mus musculus 
GN=Atp5o PE=1 SV=1 
sp|Q9DB20|ATPO_
MOUSE 23 kDa 15 0 
49 
Enoyl-CoA delta isomerase 1, mitochondrial OS=Mus 
musculus GN=Eci1 PE=2 SV=2 
sp|P42125|ECI1_M
OUSE 32 kDa 11 5 
50 Titin OS=Mus musculus GN=Ttn PE=1 SV=1 
sp|A2ASS6|TITIN_M
OUSE-R ? 2 3 
51 
Creatine kinase S-type, mitochondrial OS=Mus musculus 
GN=Ckmt2 PE=1 SV=1 
sp|Q6P8J7|KCRS_
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52 
Isocitrate dehydrogenase [NAD] subunit gamma 1, 
mitochondrial OS=Mus musculus GN=Idh3g PE=1 SV=1 
sp|P70404|IDHG1_
MOUSE 43 kDa 9 3 
53 
Trifunctional enzyme subunit beta, mitochondrial OS=Mus 
musculus GN=Hadhb PE=1 SV=1 
sp|Q99JY0|ECHB_
MOUSE 51 kDa 12 0 
54 
Long-chain specific acyl-CoA dehydrogenase, 
mitochondrial OS=Mus musculus GN=Acadl PE=2 SV=2 
sp|P51174|ACADL_
MOUSE 48 kDa 6 5 
55 
Carnitine O-palmitoyltransferase 1, muscle isoform 
OS=Mus musculus GN=Cpt1b PE=2 SV=1 
sp|Q924X2|CPT1B_
MOUSE 88 kDa 11 0 
56 
Acetyl-CoA acetyltransferase, mitochondrial OS=Mus 
musculus GN=Acat1 PE=1 SV=1 
sp|Q8QZT1|THIL_M
OUSE 45 kDa 8 2 
57 
60 kDa heat shock protein, mitochondrial OS=Mus 
musculus GN=Hspd1 PE=1 SV=1 
sp|P63038|CH60_M
OUSE 61 kDa 6 0 
58 
Dihydrolipoyllysine-residue succinyltransferase component 
of 2-oxoglutarate dehydrogenase complex, mitochondrial 
OS=Mus musculus GN=Dlst PE=1 SV=1 
sp|Q9D2G2|ODO2_
MOUSE 49 kDa 5 4 
59 
Advanced glycosylation end product-specific receptor 
OS=Mus musculus GN=Ager PE=1 SV=1 
sp|Q62151|RAGE_
MOUSE (+4) 43 kDa 4 5 
60 
Dihydrolipoyl dehydrogenase, mitochondrial OS=Mus 
musculus GN=Dld PE=1 SV=2 
sp|O08749|DLDH_M
OUSE 54 kDa 9 0 
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61 Polyubiquitin-B OS=Mus musculus GN=Ubb PE=1 SV=1 
sp|P0CG49|UBB_M
OUSE (+9) 34 kDa 0 0 
62 
Ig kappa chain V-II region 26-10 OS=Mus musculus PE=1 
SV=1 
sp|P01631|KV2A7_
MOUSE 12 kDa 0 5 
63 
Ig mu chain C region secreted form OS=Mus musculus 
GN=Igh-6 PE=1 SV=2 
sp|P01872|IGHM_M
OUSE (+1) 50 kDa 3 5 
64 
Pyruvate dehydrogenase protein X component, 
mitochondrial OS=Mus musculus GN=Pdhx PE=2 SV=1 
sp|Q8BKZ9|ODPX_
MOUSE 54 kDa 4 4 
65 
Complement C4-B OS=Mus musculus GN=C4b PE=1 
SV=3 
sp|P01029|CO4B_M
OUSE 193 kDa 3 4 
66 
Myosin light chain 1/3, skeletal muscle isoform OS=Mus 
musculus GN=Myl1 PE=1 SV=2 
sp|P05977|MYL1_M
OUSE (+1) 21 kDa 6 0 
67 
ATP synthase gamma chain OS=Mus musculus 
GN=Atp5c1 PE=3 SV=1 
tr|A2AKU9|A2AKU9
_MOUSE 33 kDa 7 0 
68 
Histone H1.4 OS=Mus musculus GN=Hist1h1e PE=1 
SV=2 
sp|P43274|H14_MO
USE 22 kDa 4 0 
69 
Eukaryotic translation initiation factor 3 subunit C OS=Mus 
musculus GN=Eif3c PE=1 SV=1 
sp|Q8R1B4|EIF3C_
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70 
Junction plakoglobin OS=Mus musculus GN=Jup PE=1 
SV=3 
sp|Q02257|PLAK_M
OUSE 82 kDa 3 4 
71 Desmoplakin OS=Mus musculus GN=Dsp PE=3 SV=1 
sp|E9Q557|DESP_
MOUSE 333 kDa 5 3 
72 
Microtubule-actin cross-linking factor 1 OS=Mus musculus 
GN=Macf1 PE=1 SV=2 
sp|Q9QXZ0|MACF1
_MOUSE (+3) 832 kDa 0 2 
73 
Electron transfer flavoprotein subunit beta OS=Mus 
musculus GN=Etfb PE=1 SV=3 
sp|Q9DCW4|ETFB_
MOUSE 28 kDa 5 1 
74 Beta-globin OS=Mus musculus GN=Hbb-b1 PE=3 SV=1 
tr|A8DUK4|A8DUK4
_MOUSE (+1) 16 kDa 7 0 
75 Isoform 2 of Sacsin OS=Mus musculus GN=Sacs 
sp|Q9JLC8-
2|SACS_MOUSE-R 
(+3) ? 3 2 
76 
Malate dehydrogenase, mitochondrial OS=Mus musculus 
GN=Mdh2 PE=1 SV=3 
sp|P08249|MDHM_
MOUSE 36 kDa 5 0 
77 
AMP deaminase 1 OS=Mus musculus GN=Ampd1 PE=2 
SV=1 
sp|Q3V1D3|AMPD1
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78 
Structural maintenance of chromosomes flexible hinge 
domain-containing protein 1 OS=Mus musculus 
GN=Smchd1 PE=2 SV=2 
sp|Q6P5D8|SMHD1
_MOUSE 226 kDa 0 2 
79 
Nascent polypeptide-associated complex subunit alpha, 
muscle-specific form OS=Mus musculus GN=Naca PE=1 
SV=2 
sp|P70670|NACAM_
MOUSE 220 kDa 2 2 
80 
Histone H2B type 1-F/J/L OS=Mus musculus 
GN=Hist1h2bf PE=1 SV=2 
sp|P10853|H2B1F_
MOUSE (+12) 14 kDa 4 0 
81 
Thioredoxin-dependent peroxide reductase, mitochondrial 
OS=Mus musculus GN=Prdx3 PE=1 SV=1 
sp|P20108|PRDX3_
MOUSE 28 kDa 4 0 
82 
Lipoamide acyltransferase component of branched-chain 
alpha-keto acid dehydrogenase complex, mitochondrial 
OS=Mus musculus GN=Dbt PE=2 SV=2 
sp|P53395|ODB2_M
OUSE 53 kDa 5 0 
83 
Glycine dehydrogenase [decarboxylating], mitochondrial 
OS=Mus musculus GN=Gldc PE=1 SV=1 
sp|Q91W43|GCSP_
MOUSE 113 kDa 0 3 
84 
Glycogen [starch] synthase, muscle OS=Mus musculus 
GN=Gys1 PE=1 SV=2 
sp|Q9Z1E4|GYS1_
MOUSE (+1) 84 kDa 5 0 
85 
Isocitrate dehydrogenase [NADP], mitochondrial OS=Mus 
musculus GN=Idh2 PE=1 SV=3 
sp|P54071|IDHP_M
OUSE 51 kDa 6 0 
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86 Kinectin OS=Mus musculus GN=Ktn1 PE=4 SV=1 
tr|F8VQC7|F8VQC7
_MOUSE-R ? 0 3 
87 
Isoform 2 of V-type proton ATPase catalytic subunit A 
OS=Mus musculus GN=Atp6v1a 
sp|P50516-
2|VATA_MOUSE 
(+2) 56 kDa 3 0 
88 
Ig gamma-2A chain C region secreted form OS=Mus 
musculus PE=1 SV=1 
sp|P01864|GCAB_M
OUSE (+1) 37 kDa 3 0 
89 
GrpE protein homolog 1, mitochondrial OS=Mus musculus 
GN=Grpel1 PE=1 SV=1 
sp|Q99LP6|GRPE1_
MOUSE 24 kDa 3 0 
90 
NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, 
mitochondrial OS=Mus musculus GN=Ndufs3 PE=1 SV=2 
sp|Q9DCT2|NDUS3
_MOUSE 30 kDa 3 0 
91 
Glyceraldehyde-3-phosphate dehydrogenase OS=Mus 
musculus GN=Gm7251 PE=3 SV=1 
tr|F6UT49|F6UT49_
MOUSE 36 kDa 3 0 
92 
Isoform 2 of A-kinase anchor protein 10, mitochondrial 
OS=Mus musculus GN=Akap10 
sp|O88845-
2|AKA10_MOUSE-R ? 2 0 
93 
Uncharacterized protein OS=Mus musculus GN=Gm10073 
PE=4 SV=1 
tr|E9Q3T0|E9Q3T0_
MOUSE 11 kDa 1 0 
94 Granulins OS=Mus musculus GN=Grn PE=1 SV=2 
sp|P28798|GRN_M
OUSE (+1) 63 kDa 0 4 
 41 
Table 3.1 The Complete List of Protein-Protein Interactions of UCP3 (Con’t) 
95 
Protein capicua homolog OS=Mus musculus GN=Cic 
PE=1 SV=2 
sp|Q924A2|CIC_MO
USE-R ? 0 2 
96 Protein Spnb4 OS=Mus musculus GN=Spnb4 PE=4 SV=1 
tr|E9PX29|E9PX29_
MOUSE (+1) 289 kDa 2 0 
97 Filamin-A OS=Mus musculus GN=Flna PE=1 SV=5 
sp|Q8BTM8|FLNA_
MOUSE (+2) 281 kDa 0 3 
98 




(+1) 253 kDa 1 0 
99 
ADP/ATP translocase 2 OS=Mus musculus GN=Slc25a5 
PE=1 SV=3 
sp|P51881|ADT2_M
OUSE 33 kDa 1 0 
100 
Aldehyde dehydrogenase, mitochondrial OS=Mus 
musculus GN=Aldh2 PE=1 SV=1 
sp|P47738|ALDH2_
MOUSE 57 kDa 4 0 
101 
Chaperone activity of bc1 complex-like, mitochondrial 
OS=Mus musculus GN=Adck3 PE=2 SV=2 
sp|Q60936|ADCK3_
MOUSE (+1) 72 kDa 5 0 
102 
Tropomodulin-3 OS=Mus musculus GN=Tmod3 PE=1 
SV=1 
sp|Q9JHJ0|TMOD3_
MOUSE 40 kDa 0 0 
103 
MCG140437, isoform CRA_d OS=Mus musculus 
GN=Myh2 PE=4 SV=1 
tr|G3UW82|G3UW8
2_MOUSE 223 kDa 4 0 
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104 
Ig gamma-1 chain C region secreted form OS=Mus 
musculus GN=Ighg1 PE=1 SV=1 
sp|P01868|IGHG1_
MOUSE (+1) 36 kDa 0 5 
105 
ATP synthase subunit d, mitochondrial OS=Mus musculus 
GN=Atp5h PE=1 SV=3 
sp|Q9DCX2|ATP5H
_MOUSE (+1) 19 kDa 5 0 
106 
Ubiquitin-protein ligase E3A OS=Mus musculus 
GN=Ube3a PE=2 SV=1 
sp|O08759|UBE3A_
MOUSE (+1) 101 kDa 0 0 
107 
Protein Ceacam13 OS=Mus musculus GN=Ceacam13 
PE=2 SV=1 
tr|Q9DAT7|Q9DAT7
_MOUSE-R (+1) ? 2 0 
108 
Isoform 2 of DnaJ homolog subfamily A member 3, 
mitochondrial OS=Mus musculus GN=Dnaja3 
sp|Q99M87-
2|DNJA3_MOUSE 
(+2) 49 kDa 2 0 
109 Protein Ahnak OS=Mus musculus GN=Ahnak PE=4 SV=1 
tr|E9Q616|E9Q616_
MOUSE 604 kDa 1 0 
110 
Uncharacterized protein KIAA0825 homolog OS=Mus 
musculus PE=2 SV=3 
sp|Q3UPC7|K0825_
MOUSE-R ? 1 0 
111 Myelin protein P0 OS=Mus musculus GN=Mpz PE=1 SV=1 
sp|P27573|MYP0_M
OUSE (+1) 28 kDa 0 3 
112 
Neurofilament heavy polypeptide OS=Mus musculus 
GN=Nefh PE=1 SV=3 
sp|P19246|NFH_MO
USE 117 kDa 1 0 
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kDa 0 2 
114 
von Willebrand factor A domain-containing protein 8 
OS=Mus musculus GN=Vwa8 PE=2 SV=2 
sp|Q8CC88|VWA8_
MOUSE 213 kDa 2 0 
115 
Thioredoxin domain-containing protein 11 OS=Mus 
musculus GN=Txndc11 PE=2 SV=1 
sp|Q8K2W3|TXD11_
MOUSE-R ? 0 2 
116 
Isoform Cytoplasmic of Fumarate hydratase, mitochondrial 
OS=Mus musculus GN=Fh 
sp|P97807-
2|FUMH_MOUSE 
(+1) 50 kDa 3 0 
117 
Retrovirus-related Pol polyprotein LINE-1 OS=Mus 
musculus GN=Pol PE=1 SV=2 
sp|P11369|POL2_M
OUSE-R ? 1 0 
118 
Glycogen phosphorylase, muscle form OS=Mus musculus 
GN=Pygm PE=1 SV=3 
sp|Q9WUB3|PYGM_
MOUSE (+1) 97 kDa 3 0 
119 
Unconventional myosin-Ia OS=Mus musculus GN=Myo1a 
PE=2 SV=2 
sp|O88329|MYO1A_
MOUSE-R ? 3 0 
120 
Medium-chain specific acyl-CoA dehydrogenase, 
mitochondrial OS=Mus musculus GN=Acadm PE=1 SV=1 
sp|P45952|ACADM_




Table 3.1 The Complete List of Protein-Protein Interactions of UCP3 (Con’t) 
121 
Aspartate-beta-hydroxylase OS=Mus musculus GN=Asph 
PE=4 SV=1 
tr|A2AL78|A2AL78_
MOUSE 26 kDa 4 0 
122 
Enoyl-CoA hydratase, mitochondrial OS=Mus musculus 
GN=Echs1 PE=1 SV=1 
sp|Q8BH95|ECHM_
MOUSE 31 kDa 4 0 
123 
60S acidic ribosomal protein P0 OS=Mus musculus 
GN=Rplp0 PE=1 SV=3 
sp|P14869|RLA0_M
OUSE (+1) 34 kDa 3 0 
124 
Triosephosphate isomerase OS=Mus musculus GN=Tpi1 
PE=3 SV=1 
tr|H7BXC3|H7BXC3
_MOUSE (+1) 18 kDa 4 0 
125 Alpha globin 1 OS=Mus musculus GN=Hba-a1 PE=2 SV=1 
tr|Q91VB8|Q91VB8_
MOUSE 15 kDa 4 0 
126 
Tubulin alpha-1B chain OS=Mus musculus GN=Tuba1b 
PE=1 SV=2 
sp|P05213|TBA1B_
MOUSE (+1) 50 kDa 2 0 
127 




(+1) ? 2 0 
128 
Protein 4930407I10Rik OS=Mus musculus 
GN=4930407I10Rik PE=4 SV=2 
tr|D3Z5T8|D3Z5T8_





Table 3.1 The Complete List of Protein-Protein Interactions of UCP3 (Con’t) 
129 Isoform 2 of Obscurin OS=Mus musculus GN=Obscn 
sp|A2AAJ9-
2|OBSCN_MOUSE 
(+3) 780 kDa 0 1 
130 
Isoform 2 of General transcription factor 3C polypeptide 1 
OS=Mus musculus GN=Gtf3c1 
sp|Q8K284-
2|TF3C1_MOUSE-R 
(+1) ? 0 1 
131 
Caspase recruitment domain-containing protein 10 
OS=Mus musculus GN=Card10 PE=2 SV=1 
sp|P58660|CAR10_
MOUSE-R (+1) ? 1 0 
132 
Protein Pcdhb1 OS=Mus musculus GN=Pcdhb1 PE=2 
SV=1 
tr|Q91Y08|Q91Y08_
MOUSE 91 kDa 1 0 
133 Nesprin-2 OS=Mus musculus GN=Syne2 PE=1 SV=2 
sp|Q6ZWQ0|SYNE2
_MOUSE-R (+1) ? 0 1 
134 
[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, 
mitochondrial OS=Mus musculus GN=Pdk4 PE=2 SV=1 
sp|O70571|PDK4_M
OUSE 47 kDa 3 0 
135 
Tropomyosin beta chain OS=Mus musculus GN=Tpm2 
PE=1 SV=1 
sp|P58774|TPM2_M
OUSE (+1) 33 kDa 3 0 
136 
Tubulin beta-4B chain OS=Mus musculus GN=Tubb4b 
PE=1 SV=1 
sp|P68372|TBB4B_
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137 
Acyl-CoA dehydrogenase family member 9, mitochondrial 
OS=Mus musculus GN=Acad9 PE=2 SV=2 
sp|Q8JZN5|ACAD9_
MOUSE 69 kDa 0 3 
138 
Nuclear pore membrane glycoprotein 210 OS=Mus 
musculus GN=Nup210 PE=1 SV=2 
sp|Q9QY81|PO210_
MOUSE-R ? 3 0 
139 




(+2) 137 kDa 0 2 
140 
Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus 
GN=Acsl1 PE=1 SV=2 
sp|P41216|ACSL1_
MOUSE (+1) 78 kDa 2 0 
141 Isoform 2 of Protein PTHB1 OS=Mus musculus GN=Bbs9 
sp|Q811G0-
2|PTHB1_MOUSE 
(+1) 98 kDa 0 1 
142 
Valine--tRNA ligase, mitochondrial OS=Mus musculus 
GN=Vars2 PE=2 SV=2 
sp|Q3U2A8|SYVM_
MOUSE (+2) 118 kDa 0 0 
143 
Probable JmjC domain-containing histone demethylation 
protein 2C OS=Mus musculus GN=Jmjd1c PE=4 SV=1 
tr|G3UZM1|G3UZM1
_MOUSE 282 kDa 1 0 
144 
Novel protein containing fibronectin type 3 FN3 domains 
OS=Mus musculus GN=Fnd3c2 PE=4 SV=1 
tr|A2AP83|A2AP83_
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145 
Fumarylacetoacetate hydrolase domain-containing protein 
2A OS=Mus musculus GN=Fahd2 PE=1 SV=1 
sp|Q3TC72|FAHD2_
MOUSE 35 kDa 2 0 
146 




(+3) 165 kDa 2 0 
147 
Hexaprenyldihydroxybenzoate methyltransferase, 
mitochondrial OS=Mus musculus GN=Coq3 PE=2 SV=1 
sp|Q8BMS4|COQ3_
MOUSE 41 kDa 2 0 
148 
Mitochondrial 2-oxoglutarate/malate carrier protein 
OS=Mus musculus GN=Slc25a11 PE=1 SV=3 
sp|Q9CR62|M2OM_
MOUSE (+1) 34 kDa 2 0 
149 
Protein Pcdhb12 OS=Mus musculus GN=Pcdhb12 PE=3 
SV=1 
tr|F6V243|F6V243_
MOUSE 87 kDa 2 0 
150 
Semaphorin-3G OS=Mus musculus GN=Sema3g PE=2 
SV=1 
sp|Q4LFA9|SEM3G
_MOUSE 87 kDa 2 0 
151 
Anthrax toxin receptor 2 OS=Mus musculus GN=Antxr2 
PE=2 SV=1 
sp|Q6DFX2|ANTR2_
MOUSE-R ? 0 2 
152 
EH domain-containing protein 2 OS=Mus musculus 
GN=Ehd2 PE=1 SV=1 
sp|Q8BH64|EHD2_
MOUSE 61 kDa 1 0 
153 Neuroligin-1 OS=Mus musculus GN=Nlgn1 PE=1 SV=2 
sp|Q99K10|NLGN1_
MOUSE 94 kDa 0 1 
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154 
Isoform SERCA2A of Sarcoplasmic/endoplasmic reticulum 
calcium ATPase 2 OS=Mus musculus GN=Atp2a2 
sp|O55143-
2|AT2A2_MOUSE-R 
(+2) ? 1 0 
155 
Fibrous sheath-interacting protein 2 OS=Mus musculus 
GN=Fsip2 PE=1 SV=3 
sp|A2ARZ3|FSIP2_
MOUSE 785 kDa 1 0 
156 
Protein Col6a3 OS=Mus musculus GN=Col6a3 PE=4 
SV=2 
tr|E9PWQ3|E9PWQ
3_MOUSE-R (+1) ? 1 0 
157 Protein Kif14 OS=Mus musculus GN=Kif14 PE=3 SV=1 
tr|E9Q3T3|E9Q3T3_
MOUSE 181 kDa 1 0 
158 Complement C3 OS=Mus musculus GN=C3 PE=1 SV=3 
sp|P01027|CO3_MO
USE 186 kDa 1 0 
159 




(+1) 47 kDa 0 0 
160 
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161 




(+1) 45 kDa 0 1 
162 
Isoform 2 of Integrator complex subunit 6 OS=Mus 
musculus GN=Ints6 
sp|Q6PCM2-
2|INT6_MOUSE (+1) 99 kDa 0 0 
163 Midasin OS=Mus musculus GN=Mdn1 PE=3 SV=1 
tr|A2ANY6|A2ANY6
_MOUSE (+1) 630 kDa 0 1 
164 
Arf-GAP with SH3 domain, ANK repeat and PH domain-
containing protein 3 OS=Mus musculus GN=Asap3 PE=2 
SV=1 
sp|Q5U464|ASAP3_
MOUSE 99 kDa 0 1 
165 
Coiled-coil domain-containing protein 66 OS=Mus 
musculus GN=Ccdc66 PE=1 SV=3 
sp|Q6NS45|CCD66_
MOUSE (+2) 107 kDa 1 0 
166 
Multidrug resistance protein 1B OS=Mus musculus 
GN=Abcb1b PE=1 SV=1 
sp|P06795|MDR1B_
MOUSE 141 kDa 0 1 
167 Integrin alpha-L OS=Mus musculus GN=Itgal PE=3 SV=1 
tr|D3Z627|D3Z627_
MOUSE 133 kDa 1 0 
168 




(+3) ? 0 1 
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169 Protein Fat1 OS=Mus musculus GN=Fat1 PE=4 SV=1 
tr|F2Z4A3|F2Z4A3_
MOUSE-R ? 0 1 
170 
60S ribosomal protein L24 OS=Mus musculus GN=Rpl24 
PE=4 SV=1 
tr|G5E8B9|G5E8B9_
MOUSE 119 kDa 1 0 
171 
Isoform 2 of Sodium/potassium/calcium exchanger 4 
OS=Mus musculus GN=Slc24a4 
sp|Q8CGQ8-
2|NCKX4_MOUSE-





Mitochondrial uncoupling protein 3 is believed to dissipate proton gradient across 
the inner mitochondrial protein and release the energy as heat. However, it is 
now a consensus that the primary role of UCP3 is not thermogenesis. Several 
theories exist regarding the function of UCP3, and several proteins binding with it 
have been identified. As it is generally believed that interacting proteins should 
be coordinating or functionally related, the endeavor we took to identify the UCP3 
interaction partners on a proteomic scale may reveal more functions of UCP3 
and help explain the existing theories. 
The proteins detected by the mass spectrometry can be grouped into several 
categories. These categories indicate the potential functions UCP3 may be 
involved in.   
(1) TCA cycle associated proteins, including malate dehydrogenase, isocitrate 
dehydrogenase subunits, isoform 2 of 2-oxoglutarate dehydrogenase, acetyl-CoA 
acetyltransferase, pyruvate dehydrogenase E1 component subunit beta, 
aconitate hydratase etc. UCP3 has been shown to influence TCA cycle by 
accelerating the electron transport chain and consequently refilling the pool of 
cofactors NAD+ and FAD2+. However, these interactions of UCP3 with the TCA 
cycle participating proteins appear to implicate a more direct role of UCP3 in 
regulating the TCA cycle.  
(2) Fatty acid oxidation and uptake related proteins, including long-chain specific 
acyl-CoA dehydrogenase, very long-chain specific acyl-CoA dehydrogenase, 
medium-chain specific acyl-CoA dehydrogenase, trifunctional enzyme subunits, 
enoyl-CoA delta isomerase 1, enoyl-CoA hydratase, carnitine O-
palmitoyltransferase 1 etc.  The enoyl-CoA hydratase, also known as 
∆3,5∆2,4dienoyl-CoA isomerase (DCI), has been previously demonstrated to 
interact with UCP3 and promote unsaturated fatty acid oxidation in a UCP3-
dependent manner. Our data confirmed this interaction, and proposed more 
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possible mechanisms how UCP3 can regulate fatty acid metabolism. In addition, 
though UCP3 itself has been speculated to directly transport fatty acid back and 
forth across the inner mitochondrial membrane, its interaction with carnitine O-
palmitoyltransferase 1 seems to imply a novel function in fatty acid uptake by 
controlling its carnitinization. Furthermore, these interactions may also involve 
the regulatory pathway of UCP3 itself. Though many experiments have 
confirmed the function of fatty acid to activate UCPs, little is known about how 
fatty acid in matrix is passed along to the UCPs on the inner membrane (Hagen 
and Lowell, 2000; Ježek, 1999; Skulachev, 1999; Žáčková et al., 2003). The 
protein bridging the gap between UCP3 and fatty acid may bind with UCP3 and 
be identified in this list. 
(3) Calcium transport related proteins, including sarcoplasmic/endoplasmic 
reticulum calcium ATPase 1, ryanodine receptor 1, calcium-binding mitochondrial 
carrier protein Aralar1, etc. Previous studies have shown the UCP3 is essential 
for calcium import into the mitochondrial matrix, but the detailed mechanism is 
still not elucidated (Trenker et al., 2007). Among these proteins, ryanodine 
receptor 1 has been proposed to be the mitochondrial calcium channel in cardiac 
muscle (Csordás et al., 2012). Thus, the ryanodine receptor 1 is highly likely to 
coordinate with UCP3 and catalyze the import of calcium into mitochondria. 
Besides, the other proteins in this group may facilitate this process as well. 
 (4) ATP synthesis and transport-related proteins, including ATP synthase 
subunit O,d and alpha, ATP synthase gamma chain, ADP/ATP translocase 1, 
and Creatine kinase S-type. UCP3 was known to influence ATP synthesis by 
reducing proton gradient and diminishing the proton motive force which ATP 
synthase utilizes. However, these interactions seem to indicate a novel 
mechanism by which UCP3 balance ATP generation and export by coordinating 
with these proteins.  
(5) ETC-related protein: Succinate dehydrogenase [ubiquinone] flavoprotein 
subunit. The only component of ETC that interacts with UCP3 at a detectable 
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level is complex II. ceUCP4, the UCP homolog in C.elegans, has been shown to 
regulate complex II-based respiration by mediating succinate import (Pfeiffer et 
al., 2011). It is likely that UCP3 use a similar mechanism to regulate 
mitochondrial respiration by affecting complex II function. 
It is noteworthy that some of the reduced interaction levels in UCP3 knock-out 
mitochondria may also be explained by decreased expression level of that 
protein. For example, in the absence of UCP3, a compensatory decrease in ETC 
protein expression levels may occur to prevent the high membrane potential and 
ROS generation. Therefore, these putative interaction partners are still to be 
validated to confirm its physiological relevance.  
To sum up, this study is the first time that the MS-based approach is used to 
investigate the component of UCP3 complex. The data we obtained will shed 
light on the mechanisms how UCP3 coordinate with different proteins and exhibit 

















Chapter 4 Uncoupling Protein 3 affect Global DNA methylation 
 
4.1 Introduction 
Since first discovered in early 1940s, epigenetics has been found to be 
associated with almost all cellular activities. Epigenetic processes can change 
gene expression and cell phenotype without changing the DNA sequences. 
Simply by modifying gene promoters or histones, transcription of a gene can be 
induced or inhibited in response to various signals. Proper function of epigenetics 
is essential for many cell functions, while dysregulation of epigenetics always 
leads to severe health conditions.  
Epigenetics includes DNA methylation and histone modifications 
(phosphorylation, methylation, acetylation, ubiquitination, etc. Among them, DNA 
methylation is the most well-characterized epigenetic modifications. DNA 
methyltransferase  (DNMT) can add a methyl group onto cytosine and produce 5-
methylcytosine. The CpG island occurs five times more frequently in gene 
promoter regions and is the most common site for DNA methylation events in 
differentiated cells. When a gene needs to be suppressed, its CpG island in 
promoter region will be methylated and transcription will be inhibited. Conversely, 
the gene expression can be activated by demethylation of 5-methylcytosine 
catalyzed by DNA demethylase. 
By far no existing evidence has shown UCP3 has an effect on DNA methylation 
level. However, many diseases that UCP3 opposes (including cancers and 
diabetes) are characterized by epigenetics-associated aberrant gene expression 
(Esteller, 2002, Ehrlich, 2002; Weinhold, 2006). As the presence of UCP3 can 
protect against these diseases, it should be able to maintain the normal 
epigenetic marks on genomic DNA. In addition, defective metabolism (especially 
the accumulation of ROS) is known as the leading contributor to the aberrant 
epigenetic changes. Considering the pivotal role UCP3 plays in regulating 
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respiratory efficiency and ROS scavenging, we hypothesized UCP3 has an 
indirect effect on regulating DNA methylation.  
To test the effect of UCP3 on DNA methylation, we conducted a pivot study to 
measure the global DNA methylation level in the presence or absence of UCP3. 
We used the skeletal muscle tissues isolated from UCP3 wild-type mice, UCP3 
knock-out mice and transgenic mice that modestly (3-5 fold) overexpress UCP3 
in skeletal muscle. If the hypothesis is true, the global DNA methylation in UCP3 
knock-out muscle tissue should be significantly different from UCP3 wild-type 




Our hypothesis that the absence of UCP3 can influence the global DNA 
methylation level significantly is confirmed by the ELISA-based approach. The 
experiment was repeated four times. Each time the result demonstrated a 
consistent tendency that UCP3 knock-out skeletal muscle tissues acquire 
hypermethylation in genomic DNA compared to UCP3 wild-type and transgenic 
tissues. According to the data, the UCP3 wild-type and knock-out genomic DNA 
have average global methylation levels that are 28% and 45% of the control DNA 
respectively. Since the fully methylated control DNA does not come from mouse, 
these percentages cannot represent the real DNA methylation level in UCP3 
wild-type and knock-out skeletal muscle tissues. In this sense, the genomic DNA 
methylation levels of knock-out group and transgenic group are normalized to the 
wild-type control group, and figure 4.1 represent the fold change between the 
three groups. As shown by the figure, UCP3 knock-out mice have an average 
1.5-fold higher genomic DNA methylation level compared to the wild-type 







Figure 4.1 Genomic DNA isolated from UCP3 knock-out mice shows 
significantly induced global methylation level compared to UCP3 wild-type 
mice. The genomic DNA methylation level as expressed as fold-change relative 
to the wild-type control group. There is statistically significant difference between 
wild-type control group and UCP3 knock-out group. Assays were performed as 










Although it is well-established that metabolism plays a key role in the modulation 
of epigenetic processes, the relationship between uncoupling protein 3 and 
epigenetics has rarely been reported.  
The prototypical UCPs (UCP1-3) are known for their ability to regulate proton 
conductance across the inner mitochondrial membrane and drive mitochondrial 
respiration. Consequently, UCP3 has been implicated in a number of metabolic 
functions, including ROS elimination and fatty acid transport. There are several 
putative mechanisms by which UCP3 can influence epigenetics: (1) By regulating 
the redox state in mitochondria, UCP3 may activate or inactivate DNMT and lead 
to DNA hypermethylation or hypomethylation respectively. (2) UCP3 can refuel 
the TCA cycle by liberating coenzyme A from fatty acid, which prevent the 
accumulation of TCA cycle metabolites. As succinate and fumarate have been 
shown to inhibit DNA demethylase, the normal function of TCA cycle is believed 
to be protective against abnormal epigenetic changes (Xiao et al., 2012).   
We conducted the ELISA-based experiment to learn the effect of UCP3 on 
genomic DNA methylation levels. The result we observed supports our 
hypothesis that the absence of UCP3 will lead to a significant change in global 
DNA methylation level. Through this analysis we are able to establish a novel 
function of UCP3 in regulating the epigenetic processes in mammals. Additional 
experiments still need to be performed to investigate the detailed mechanism by 
which UCP3 regulate DNA methylation level. 
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Chapter 5 Concluding remarks and future directions 
 
Since its discovery in 1997, there has been lots of controversy revolving the 
physiological or biochemical function of mitochondrial uncoupling protein 3 
(UCP3). Just like UCP1, UCP3 is localized in the inner mitochondrial membrane 
and dissipate the proton gradient into the matrix. However, it was later 
demonstrated that UCP3 do not have the same function in maintaining body 
temperature as UCP1 (Vidal-Puig, Grujic et al. 2000).  Though UCP3 has been 
related to promote thermogenesis in response to various stimuli, it is widely 
believed that UCP3 has more general roles in metabolism. UCP3 is primarily 
expressed in tissues with high metabolic rate, including heart, brown fat, and 
skeletal muscle (Vidal-Puig, Solanes et al. 1997). Given the huge mass of 
skeletal muscle, the UCP3-dependent mitochondrial uncoupling is speculated to 
have a significant role in the whole body metabolism. 
Several mechanisms have been proposed as to the biochemical roles of UCP3. 
And some proteins that interact with UCP3 and facilitate its different functions 
have been identified and investigated. However, as more and more UCP3 
interaction partners are discovered, we believe that UCP3 form a multi-protein 
complex, which may be involved in many different roles and be regulated by 
various signals. To validate our hypothesis, we performed a mass spectrometry-
based analysis trying to identify the all components of UCP3 complex. More than 
170 proteins were detected, most of which are related to at least one of the 5 
following processes: TCA cycle, fatty acid metabolism and transport, calcium 
uptake, ATP synthesis and translocation, and electron transport chain. Though 
these protein-protein interactions with UCP3 are still to be confirmed by further 
experiment, these 5 groups will provide the directions for UCP3 study in the 
future.  
The physiological roles of UCP3 have also been associated with the prevention 
of obesity, insulin resistance, type II diabetes and even cancer. Since all these 
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diseases are generally coupled with aberrant gene expression caused by 
epigenetic changes, the protective role of UCP3 may also include the 
maintenance of normal epigenetic marks. To answer this question, we conducted 
a pilot study on the effect of UCP3 deletion on DNA methylation level. The 
experiment result showed that UCP3 deficiency in animal muscle tissue 
contributes to genomic DNA hypermethylation, supporting the novel function of 
UCP3 in the maintenance of epigenetic processes. As the exact mechanism by 
which UCP3 regulate epigenetics are still unknown, further reports to explain the 
whole pathway are still needed. This model provides an explanation about how 
UCP3 can defend against the above-mentioned diseases, and may provide 



















Barreiro, E., Garcia-Martínez, C., Mas, S., Ametller, E., Gea, J., Argilés, J.M., 
Busquets, S., and López-Soriano, F.J. (2009). UCP3 overexpression neutralizes 
oxidative stress rather than nitrosative stress in mouse myotubes. FEBS Lett. 
583, 350–356. 
Barrès, R., Yan, J., Egan, B., Treebak, J.T., Rasmussen, M., Fritz, T., Caidahl, 
K., Krook, A., O’Gorman, D.J., and Zierath, J.R. (2012). Acute Exercise 
Remodels Promoter Methylation in Human Skeletal Muscle. Cell Metab. 15, 405–
411. 
Bezaire, V., Spriet, L.L., Campbell, S., Sabet, N., Gerrits, M., Bonen, A., and 
Harper, M.-E. (2005). Constitutive UCP3 overexpression at physiological levels 
increases mouse skeletal muscle capacity for fatty acid transport and oxidation. 
FASEB J. 
Bézaire, V., Seifert, E.L., and Harper, M.-E. (2007). Uncoupling protein-3: clues 
in an ongoing mitochondrial mystery. FASEB J. 21, 312–324. 
Boss, O., Samec, S., Paoloni-Giacobino, A., Rossier, C., Dulloo, A., Seydoux, J., 
Muzzin, P., and Giacobino, J.-P. (1997). Uncoupling protein-3: a new member of 
the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 408, 
39–42. 
Boss, O., Samec, S., Kühne, F., Bijlenga, P., Assimacopoulos-Jeannet, F., 
Seydoux, J., Giacobino, J.-P., and Muzzin, P. (1998). Uncoupling Protein-3 
Expression in Rodent Skeletal Muscle Is Modulated by Food Intake but Not by 
Changes in Environmental Temperature. J. Biol. Chem. 273, 5–8. 
Bouillaud, F., Ricquier, D., Thibault, J., and Weissenbach, J. (1985). Molecular 
approach to thermogenesis in brown adipose tissue: cDNA cloning of the 
mitochondrial uncoupling protein. Proc. Natl. Acad. Sci. U. S. A. 82, 445–448. 
Boyer, P.D. (1997). The Atp Synthase—a Splendid Molecular Machine. Annu. 
Rev. Biochem. 66, 717–749. 
Brand, M.D., and Esteves, T.C. (2005). Physiological functions of the 
mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab. 2, 85–93. 
Cannon, B., and Nedergaard, J. (2004). Brown Adipose Tissue: Function and 
Physiological Significance. Physiol. Rev. 84, 277–359. 
Cannon, B., Hedin, A., and Nedergaard, J. (1982). Exclusive occurrence of 
thermogenin antigen in brown adipose tissue. FEBS Lett. 150, 129–132. 
Cedar, H., and Bergman, Y. (2009). Linking DNA methylation and histone 
modification: patterns and paradigms. Nat. Rev. Genet. 10, 295–304. 
 61 
Cervera, A.M., Bayley, J.-P., Devilee, P., and McCreath, K.J. (2009). Inhibition of 
succinate dehydrogenase dysregulates histone modification in mammalian cells. 
Mol. Cancer 8, 89. 
Chan, C.B., and Harper, M.-E. (2006). Uncoupling Proteins: Role in Insulin 
Resistance and Insulin Insufficiency. Curr. Diabetes Rev. 2, 271–283. 
Chan, C.B., MacDonald, P.E., Saleh, M.C., Johns, D.C., Marbàn, E., and 
Wheeler, M.B. (1999). Overexpression of uncoupling protein 2 inhibits glucose-
stimulated insulin secretion from rat islets. Diabetes 48, 1482–1486. 
Chan, C.B., Leo, D.D., Joseph, J.W., McQuaid, T.S., Ha, X.F., Xu, F., Tsushima, 
R.G., Pennefather, P.S., Salapatek, A.M.F., and Wheeler, M.B. (2001). Increased 
Uncoupling Protein-2 Levels in β-cells Are Associated With Impaired Glucose-
Stimulated Insulin Secretion Mechanism of Action. Diabetes 50, 1302–1310. 
Chowdhury, R., Yeoh, K.K., Tian, Y.-M., Hillringhaus, L., Bagg, E.A., Rose, N.R., 
Leung, I.K.H., Li, X.S., Woon, E.C.Y., Yang, M., et al. (2011). The 
oncometabolite 2‐ hydroxyglutarate inhibits histone lysine demethylases. EMBO 
Rep. 12, 463–469. 
Clapham JC, Arch JR, Chapman H, Haynes A, Lister C, Moore GB, Piercy V, 
Carter SA, Lehner I, Smith SA, Beeley LJ, Godden RJ, Herrity N, Skehel M, 
Changani KK, Hockings PD, Reid DG, Squires SM, Hatcher J, Trail B, Latcham 
J, Rastan S, Harper AJ, Cadenas S, Buckingham JA, Brand MD, Abuin A.(2000). 
Mice overexpressing human uncoupling protein-3 in skeletal muscle are 
hyperphagic and lean : Article : Nature. Nature 406, 415–418. 
Coppola, A., Liu, Z.-W., Andrews, Z.B., Paradis, E., Roy, M.-C., Friedman, J.M., 
Ricquier, D., Richard, D., Horvath, T.L., Gao, X.-B., et al. (2007). A Central 
Thermogenic-like Mechanism in Feeding Regulation: An Interplay between 
Arcuate Nucleus T3 and UCP2. Cell Metab. 5, 21–33. 
Csordás, G., Várnai, P., Golenár, T., Sheu, S.-S., and Hajnóczky, G. (2012). 
Calcium transport across the inner mitochondrial membrane: Molecular 
mechanisms and pharmacology. Mol. Cell. Endocrinol. 353, 109–113. 
Donkena, K.V., Young, C.Y.F., and Tindall, D.J. (2010). Oxidative Stress and 
DNA Methylation in Prostate Cancer. Obstet. Gynecol. Int. 2010, e302051. 
Echtay, K.S., Roussel, D., St-Pierre, J., Jekabsons, M.B., Cadenas, S., Stuart, 
J.A., Harper, J.A., Roebuck, S.J., Morrison, A., Pickering, S., et al. (2002). 
Superoxide activates mitochondrial uncoupling proteins. Nature 415, 96–99. 
Echtay, K.S., Esteves, T.C., Pakay, J.L., Jekabsons, M.B., Lambert, A.J., 
Portero-Otin, M., Pamplona, R., Vidal-Puig, A.J., Wang, S., Roebuck, S.J., et al. 
(2003). A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial 
uncoupling. EMBO J. 22, 4103–4110. 
 62 
Enerbäck, S., Jacobsson, A., Simpson, E.M., Guerra, C., Yamashita, H., Harper, 
M.-E., and Kozak, L.P. (1997). Mice lacking mitochondrial uncoupling protein are 
cold-sensitive but not obese. Nature 387, 90–94. 
Enrlich, M. (2002). DNA methylation in cancer: too much, but also too little. Publ. 
Online 05 August 2002 Doi101038sjonc1205651 21. 
Estellar, M. (2002). CpG island hypermethylation and tumor suppressor genes: a 
booming present, a brighter future. Publ. Online 05 August 2002 
Doi101038sjonc1205600 21. 
Esteves, T.C., and Brand, M.D. (2005). The reactions catalysed by the 
mitochondrial uncoupling proteins UCP2 and UCP3. Biochim. Biophys. Acta BBA 
- Bioenerg. 1709, 35–44. 
Fedorenko, A., Lishko, P.V., and Kirichok, Y. (2012). Mechanism of Fatty-Acid-
Dependent UCP1 Uncoupling in Brown Fat Mitochondria. Cell 151, 400–413. 
Feldmann, H.M., Golozoubova, V., Cannon, B., and Nedergaard, J. (2009). 
UCP1 Ablation Induces Obesity and Abolishes Diet-Induced Thermogenesis in 
Mice Exempt from Thermal Stress by Living at Thermoneutrality. Cell Metab. 9, 
203–209. 
Figueroa, M.E., Abdel-Wahab, O., Lu, C., Ward, P.S., Patel, J., Shih, A., Li, Y., 
Bhagwat, N., Vasanthakumar, A., Fernandez, H.F., et al. (2010). Leukemic IDH1 
and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 
Function, and Impair Hematopoietic Differentiation. Cancer Cell 18, 553–567. 
Fleury, C., Neverova, M., Collins, S., Raimbault, S., Champigny, O., Levi-
Meyrueis, C., Bouillaud, F., Seldin, M.F., Surwit, R.S., Ricquier, D., et al. (1997). 
Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat. 
Genet. 15, 269–272. 
Garlid, K.D., Jabůrek, M., and Ježek, P. (1998). The mechanism of proton 
transport mediated by mitochondrial uncoupling proteins. FEBS Lett. 438, 10–14. 
Golozoubova, V., Hohtola, E., Matthias, A., Jacobsson, A., Cannon, B., and 
Nedergaard, J. (2001). Only UCP1 can mediate adaptive nonshivering 
thermogenesis in the cold. FASEB J. 
Gong, D.-W., He, Y., Karas, M., and Reitman, M. (1997). Uncoupling Protein-3 Is 
a Mediator of Thermogenesis Regulated by Thyroid Hormone, β3-Adrenergic 
Agonists, and Leptin. J. Biol. Chem. 272, 24129–24132. 
Graier, W.F., Trenker, M., and Malli, R. (2008). Mitochondrial Ca2+, the secret 
behind the function of uncoupling proteins 2 and 3? Cell Calcium 44, 36–50. 
 63 
Hagen, T., and Lowell, B.B. (2000). Chimeric Proteins between UCP1 and UCP3: 
The Middle Third of UCP1 Is Necessary and Sufficient for Activation by Fatty 
Acids. Biochem. Biophys. Res. Commun. 276, 642–648. 
He, J., Xu, Q., Jing, Y., Agani, F., Qian, X., Carpenter, R., Li, Q., Wang, X.-R., 
Peiper, S.S., Lu, Z., et al. (2012). Reactive oxygen species regulate ERBB2 and 
ERBB3 expression via miR‐ 199a/125b and DNA methylation. EMBO Rep. 13, 
1116–1122. 
Himms-Hagen, J., and Harper, M.-E. (2001). Physiological Role of UCP3 May Be 
Export of Fatty Acids from Mitochondria When Fatty Acid Oxidation 
Predominates: An Hypothesis. Exp. Biol. Med. 226, 78–84. 
Hirasaka, K., Lago, C.U., Kenaston, M.A., Fathe, K., Nowinski, S.M., Nikawa, T., 
and Mills, E.M. (2011). Identification of a Redox-Modulatory Interaction Between 
Uncoupling Protein 3 and Thioredoxin 2 in the Mitochondrial Intermembrane 
Space. Antioxid. Redox Signal. 15, 2645–2661. 
Hitchler, M.J., and Domann, F.E. (2009). Metabolic defects provide a spark for 
the epigenetic switch in cancer. Free Radic. Biol. Med. 47, 115–127. 
Hittelman, K.J., Lindberg, O., and Cannon, B. (1969). Oxidative Phosphorylation 
and Compartmentation of Fatty Acid Metabolism in Brown Fat Mitochondria. Eur. 
J. Biochem. 11, 183–192. 
Hood, D.A. (2009). Mechanisms of exercise-induced mitochondrial biogenesis in 
skeletal muscleThis paper is one of a selection of papers published in this 
Special Issue, entitled 14th International Biochemistry of Exercise Conference – 
Muscles as Molecular and Metabolic Machines, and has undergone the Journal’s 
usual peer review process. Appl. Physiol. Nutr. Metab. 34, 465–472. 
Huang, S.-G. (2003). Limited proteolysis reveals conformational changes in 
uncoupling protein-1 from brown adipose tissue mitochondria. Arch. Biochem. 
Biophys. 420, 40–45. 
Iser, W.B., Kim, D., Bachman, E., and Wolkow, C. (2005). Examination of the 
requirement for ucp-4, a putative homolog of mammalian uncoupling proteins, for 
stress tolerance and longevity in C. elegans. Mech. Ageing Dev. 126, 1090–
1096. 
Ivanova, M.V., Hoang, T., McSorley, F.R., Krnac, G., Smith, M.D., and Jelokhani-
Niaraki, M. (2010). A Comparative Study on Conformation and Ligand Binding of 
the Neuronal Uncoupling Proteins. Biochemistry (Mosc.) 49, 512–521. 
Jabůrek, M., and Garlid, K.D. (2003). Reconstitution of Recombinant Uncoupling 
Proteins UCP1, -2, AND -3 HAVE SIMILAR AFFINITIES FOR ATP AND ARE 
UNAFFECTED BY COENZYME Q10. J. Biol. Chem. 278, 25825–25831. 
 64 
Ježek, P. (1999). Fatty Acid Interaction with Mitochondrial Uncoupling Proteins. 
J. Bioenerg. Biomembr. 31, 457–466. 
Ježek, P., Costa, A.D.T., and Vercesi, A.E. (1996). Evidence for Anion-
translocating Plant Uncoupling Mitochondrial Protein in Potato Mitochondria. J. 
Biol. Chem. 271, 32743–32748. 
Ježek, P., Modrianský, M., and Garlid, K.D. (1997). A structure–activity study of 
fatty acid interaction with mitochondrial uncoupling protein. FEBS Lett. 408, 166–
170. 
Ježek, P., Engstová, H., Žáčková, M., Vercesi, A.E., Costa, A.D.T., Arruda, P., 
and Garlid, K.D. (1998). Fatty acid cycling mechanism and mitochondrial 
uncoupling proteins. Biochim. Biophys. Acta BBA - Bioenerg. 1365, 319–327. 
Kang, K.A., Zhang, R., Kim, G.Y., Bae, S.C., and Hyun, J.W. (2012). Epigenetic 
changes induced by oxidative stress in colorectal cancer cells: methylation of 
tumor suppressor RUNX3. Tumor Biol. 33, 403–412. 
Kim-Han, J.S., Reichert, S.A., Quick, K.L., and Dugan, L.L. (2001). BMCP1: a 
mitochondrial uncoupling protein in neurons which regulates mitochondrial 
function and oxidant production. J. Neurochem. 79, 658–668. 
Klaus, S., Seivert, A., and Boeuf, S. (2001). Effect of the β3-adrenergic agonist 
Cl316,243 on functional differentiation of white and brown adipocytes in primary 
cell culture. Biochim. Biophys. Acta BBA - Mol. Cell Res. 1539, 85–92. 
Klingenberg, M., and Huang, S.-G. (1999). Structure and function of the 
uncoupling protein from brown adipose tissue. Biochim. Biophys. Acta BBA - 
Biomembr. 1415, 271–296. 
Korshunov, S.S., Skulachev, V.P., and Starkov, A.A. (1997). High protonic 
potential actuates a mechanism of production of reactive oxygen species in 
mitochondria. FEBS Lett. 416, 15–18. 
Krauss, S., Zhang, C.-Y., and Lowell, B.B. (2005). The mitochondrial uncoupling-
protein homologues. Nat. Rev. Mol. Cell Biol. 6, 248–261. 
Lago, C., Nowinski, S., Rundhaug, J., Pfeiffer, M., Kiguchi, K., Hirasaka, K., 
Yang, X., Abramson, E., Bratton, S., Rho, O., et al. (2012). Mitochondrial 
respiratory uncoupling promotes keratinocyte differentiation and blocks skin 
carcinogenesis. Oncogene 31, 4725–4731. 
Laloi, M., Klein, M., Riesmeier, J.W., Müller-Röber, B., Fleury, C., Bouillaud, F., 
and Ricquier, D. (1997). A plant cold-induced uncoupling protein. Nature 389, 
135–136. 
 65 
Larkin, S., Mull, E., Miao, W., Pittner, R., Albrandt, K., Moore, C., Young, A., 
Denaro, M., and Beaumont, K. (1997). Regulation of the Third Member of the 
Uncoupling Protein Family, UCP3, by Cold and Thyroid Hormone. Biochem. 
Biophys. Res. Commun. 240, 222–227. 
Li, E. (2002). Chromatin modification and epigenetic reprogramming in 
mammalian development. Nat. Rev. Genet. 3, 662–673. 
Li, L.-C., Carroll, P.R., and Dahiya, R. (2005). Epigenetic Changes in Prostate 
Cancer: Implication for Diagnosis and Treatment. J. Natl. Cancer Inst. 97, 103–
115. 
Li, L.-X., Skorpen, F., Egeberg, K., Jørgensen, I.H., and Grill, V. (2001). 
Uncoupling Protein-2 Participates in Cellular Defense against Oxidative Stress in 
Clonal β-Cells. Biochem. Biophys. Res. Commun. 282, 273–277. 
Li, Y., Maedler, K., Shu, L., and Haataja, L. (2008). UCP-2 and UCP-3 Proteins 
Are Differentially Regulated in Pancreatic Beta-Cells. PLoS ONE 3, e1397. 
Lim, S.-O., Gu, J.-M., Kim, M.S., Kim, H.-S., Park, Y.N., Park, C.K., Cho, J.W., 
Park, Y.M., and Jung, G. (2008). Epigenetic Changes Induced by Reactive 
Oxygen Species in Hepatocellular Carcinoma: Methylation of the E-cadherin 
Promoter. Gastroenterology 135, 2128–2140.e8. 
Liu, D., Chan, S.L., Souza-Pinto, N.C. de, Jr, J.R.S., Wersto, R.P., Zhan, M., 
Mustafa, K., Cabo, R. de, and Mattson, M.P. (2006). Mitochondrial UCP4 
mediates an adaptive shift in energy metabolism and increases the resistance of 
neurons to metabolic and oxidative stress. NeuroMolecular Med. 8, 389–413. 
Maloney, P.C. (1990). A consensus structure for membrane transport. Res. 
Microbiol. 141, 374–395. 
Mao, W., Yu, X.X., Zhong, A., Li, W., Brush, J., Sherwood, S.W., Adams, S.H., 
and Pan, G. (1999). UCP4, a novel brain-specific mitochondrial protein that 
reduces membrane potential in mammalian cells. FEBS Lett. 443, 326–330. 
Matthias, A., Ohlson, K.B.E., Fredriksson, J.M., Jacobsson, A., Nedergaard, J., 
and Cannon, B. (2000). Thermogenic Responses in Brown Fat Cells Are Fully 
UCP1-dependent UCP2 OR UCP3 DO NOT SUBSTITUTE FOR UCP1 IN 
ADRENERGICALLY OR FATTY ACID-INDUCED THERMOGENESIS. J. Biol. 
Chem. 275, 25073–25081. 
Mattiasson, G., and Sullivan, P.G. (2006). The Emerging Functions of UCP2 in 
Health, Disease, and Therapeutics. Antioxid. Redox Signal. 8, 1–38. 
Mattson, M.P., and Liu, D. (2003). Mitochondrial potassium channels and 
uncoupling proteins in synaptic plasticity and neuronal cell death. Biochem. 
Biophys. Res. Commun. 304, 539–549. 
 66 
Mills, E.M., Banks, M.L., Sprague, J.E., and Finkel, T. (2003). Pharmacology: 
Uncoupling the agony from ecstasy. Nature 426, 403–404. 
Moreno-Sánchez, R., Rodríguez-Enríquez, S., Marín-Hernández, A., and 
Saavedra, E. (2007). Energy metabolism in tumor cells. FEBS J. 274, 1393–
1418. 
Mori, S., Yoshizuka, N., Takizawa, M., Takema, Y., Murase, T., Tokimitsu, I., and 
Saito, M. (2008). Expression of Uncoupling Proteins in Human Skin and Skin-
Derived Cells. J. Invest. Dermatol. 128, 1894–1900. 
Naviaux, R.K. (2008). Mitochondrial control of epigenetics. Cancer Biol. Ther. 7, 
1191–1193. 
Nedergaard, J., Bengtsson, T., and Cannon, B. (2007). Unexpected evidence for 
active brown adipose tissue in adult humans. Am. J. Physiol. - Endocrinol. 
Metab. 293, E444–E452. 
Nicholls, D.G. (1976). Hamster Brown-Adipose-Tissue Mitochondria. Eur. J. 
Biochem. 62, 223–228. 
Nicholls, D.G. (2006). The physiological regulation of uncoupling proteins. 
Biochim. Biophys. Acta BBA - Bioenerg. 1757, 459–466. 
Palmieri, F. (2004). The mitochondrial transporter family (SLC25): physiological 
and pathological implications. Pflüg. Arch. 447, 689–709. 
Parker, N., Vidal-Puig, A., and Brand, M.D. (2008). Stimulation of mitochondrial 
proton conductance by hydroxynonenal requires a high membrane potential. 
Biosci. Rep. 28, 83–88. 
Parker, N., Crichton, P.G., Vidal-Puig, A.J., and Brand, M.D. (2009). Uncoupling 
protein-1 (UCP1) contributes to the basal proton conductance of brown adipose 
tissue mitochondria. J. Bioenerg. Biomembr. 41, 335–342. 
Pfeiffer, M., Kayzer, E.-B., Yang, X., Abramson, E., Kenaston, M.A., Lago, C.U., 
Lo, H.-H., Sedensky, M.M., Lunceford, A., Clarke, C.F., et al. (2011). 
Caenorhabditis elegans UCP4 Protein Controls Complex II-mediated Oxidative 
Phosphorylation through Succinate Transport. J. Biol. Chem. 286, 37712–37720. 
Porter, R.K. (2008). Uncoupling protein 1: a short-circuit in the chemiosmotic 
process. J. Bioenerg. Biomembr. 40, 457–461. 
Quan, X., Lim, S.-O., and Jung, G. (2011). Reactive oxygen species 
downregulate catalase expression via methylation of a CpG Island in the Oct-1 
promoter. FEBS Lett. 585, 3436–3441. 
 67 
Robinson, A.J., Overy, C., and Kunji, E.R.S. (2008). The mechanism of transport 
by mitochondrial carriers based on analysis of symmetry. Proc. Natl. Acad. Sci. 
105, 17766–17771. 
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